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Over the past 20 years, the understanding of the role of physical activity in cancer 
has been increased. Traditionally, patients were advised to rest, recovery, and save 
energy during and after anticancer treatments. Nevertheless, it is now clear that 
physical activity may help alleviate some side effects caused by therapies and a 
sedentary lifestyle; consequently, cancer patients should be encouraged to perform 
exercise. 
Epidemiological evidence shows that post-diagnosis physical activity is associated 
with enhancing patients ‘survival, especially in breast, colon, and prostate cancer. 
In cancer patients, exercise acts by improving health-related skills, particularly 
cardiorespiratory fitness, strength, and body composition. Moreover, several trials 
demonstrated that a regular exercise program effectively relieves some cancer and 
treatments ‘side effects, such as fatigue, nausea, and vomiting, thereby improving 
patients’ quality of life. The last update of the American College of Sports 
Medicine’ guidelines recommends that patients perform 90 minutes per week of 
aerobic exercise at moderate intensity, with strength activities twice a week.  
Despite these important benefits, in Italy, the spread of exercise-oncology programs 
and the research in the exercise oncology field are still poor, negatively impacting 
patients and producing a gap in the literature.  
The purpose of this thesis is trying to fill this gap, increasing the available literature, 
and proposing an exercise program based on patients’ needs and the current 
guidelines. Chapter one is dedicated to a brief introduction about physical activity 
in cancer. In chapters two, three, four, and five, the experimental studies that led to 
the development of patient-centred exercise program are presented. Chapters six 
and seven report two other studies investigating exercise as part of the multimodal 
approach in counteracting cancer cachexia. The last chapter is dedicated to a 







La comprensione del ruolo svolto dall’attività fisica dopo la diagnosi di cancro si è 
ampliata negli ultimi 20 anni. Tradizionalmente, durante e dopo il trattamento 
antitumorale ai pazienti veniva consigliato il risposo ed il risparmio di energie, 
tuttavia ora si è capito che l’attività fisica può aiutare ad alleviare alcuni effetti 
collaterali causati dalle terapie e dalla sedentarietà, e per questo motivo anche le 
persone con diagnosi di cancro dovrebbero essere incoraggiate a svolgere un 
programma regolare di esercizio fisico. 
Evidenze epidemiologiche mostrano come l’attività fisica svolta dopo la diagnosi 
sia associata ad una diminuzione del rischio di mortalità, specialmente nei tumori 
della mammella, del colon e della prostata. L’esercizio fisico agisce migliorando le 
capacità salute-correlate nei pazienti, in particolare la fitness cardiorespiratoria, la 
forza muscolare e la composizione corporea. Numerosi trials hanno mostrato inoltre 
come un programma regolare di esercizio risulti efficace nell’alleviare alcuni effetti 
collaterali del cancro e delle sue terapie, come ad esempio la fatica cancro-correlata 
i sintomi di nausea e vomito, migliorando di conseguenza la qualità della vita dei 
pazienti. Le ultime linee guida dell’American College of Sports Medicine 
raccomandano ai pazienti di svolgere circa 90 minuti settimanali di esercizio 
aerobico ad intensità moderata inserendo almeno due volte settimanali attività di 
forza. 
Nonostante i numerosi benefici derivanti dall’attività fisica, in Italia sia la 
diffusione, ma anche la ricerca riguardante l’esercizio fisico in oncologia risultano 
ancora scarsi, generando da un lato un impatto negativo per i pazienti e dall’altra 
un gap all’interno della letteratura internazionale. 
Lo scopo di questa tesi è di cercare di colmare queste lacune, aumentando la 
letteratura disponibile, arrivando a proporre un programma di esercizio fisico basato 
sulle evidenze e sulle necessità dei pazienti. Il capitolo uno è dedicato ad una breve 
introduzione e panoramica dell’attività fisica nelle patologie oncologiche. Nel 
capitolo due, tre, quattro e cinque vengo presentati gli studi sperimentali che hanno 
portato allo sviluppo di un programma di esercizio fisico basato sulle esigenze dei 
pazienti e sulle attuali linee guida. I capitoli sei e sette riportano altri due studi 
9 
 
riguardanti l’esercizio fisico, come parte dell’approccio multidisciplinare nel 
contrastare la cachessia neoplastica, mentre l’ultimo capitolo è dedicato ad un 








OVERVIEW OF CANCER DISEASE 
 
The term cancer derives from Greek “karkinos”, i.e. crab, and refers to a group 
about 200 different diseases characterized by abnormal cell growth, and released 
from the body’s normal control mechanisms (1).  
Noncommunicable diseases represent the leading cause of death globally, and 
cancer is expected to become the major responsible cause of mortality in the 21st 
century. In 2018, 18.1 million new cancer cases and 9.6 million deaths from cancer 
had been estimated worldwide (2). For both sexes combined, lung cancer (11,6%) 
is the most diagnosed cancer, followed by female breast cancer (11,6%) and 
colorectal cancer (10,2%). Regarding the mortality, lung cancer (18,4%) still 
remains the deadliest malignancy, followed by colorectum (9,2%) and stomach 
(8,2%) (2).  
In Italy, it is estimated that 377.000 newly cancer cases will be diagnosed in 2020. 
Breast cancer is the most frequently diagnosed cancer (14,6% of all cancer), 
followed by colorectum (11,6%) and lung (10,9%). Similarly to worldwide data, 
lung cancer (18,8%) is the highest cause of cancer-specific mortality, followed by 
colorectum (10,8%) and breast (7,2%) (1). However, the improvement in the 
screening programs and cancer treatments led to an increase in the number of people 
living with cancer. Indeed, in 2020, about 3.609.135 of Italian people live with a 
cancer diagnosis, representing the 5,7% of the Italian population (1).  
As previously mentioned, cancer is characterized by uncontrolled cellular growth, 
resulting in cells' genetic information changes. Cancer cells, often originated by a 
single cell, are affected by a sequential series of genome alterations, transmitted to 
cell progeny. The cause of genomic damage can be endogenous and/or exogenous 
(environmental), as the lack of physical activity. 
However, physical activity is emerging as a preventive factor against cancer and as 
an adjunct “therapy” during and after cancer treatments, being associated with 
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several benefits (e.g., reduction in cancer-related fatigue or improvement in the 
quality of life). 
 
 
PHYSICAL ACTIVITY AND CANCER PREVENTION 
 
Convincing epidemiological evidence shows that physical activity diminishes the 
risk of developing several cancer types, and for this reason, American Cancer 
Society (3) includes it among the preventive strategies. Indeed, the exposure to 
“physiological” lifestyle behavior might prevent the cancer risk, making physical 
activity a potential approach to delay the carcinogenesis.  
Recently, Moore and colleagues have performed a pooled analysis to evaluate the 
association between leisure-time physical activity and risk of 26 different cancer 
types (4). To date, this investigation results the largest, including a total of 1.44 
million participants and 186,932 cancer cases. After a categorization of participants 
‘self-reported physical activity into higher level (90th percentile) and lower level of 
activity (10th percentile), Moore found a strong inverse association for seven 
cancers (esophageal adenocarcinoma, liver, lung kidney, gastric cardia, 
endometrium and myeloid leukemia). Moderate correlation was observed for 
myeloma, colon cancer, head and neck cancer, bladder cancer, rectal cancer, and 
breast cancer, while an increase in risk was found for prostate cancer and 
melanoma. The adjustment for body mass index modestly modified the association, 
making the relationship for endometrial, liver, and gastric cardias not significant 
(4). These findings were also supported by the recent International consensus 
guideline panel (Table 1.). Indeed, the last update of the American College of Sports 
Medicine reports that physical activity lowers risk of colon, breast, kidney, 
endometrial, bladder, esophageal and stomach cancer, with strong level of evidence 
and a magnitude of association ranging between 10% and 24% (5). Moderate level 
of evidence exists for lung cancer prevention, while as suggest by Moore at al., an 











Esophageal (adenocarcinoma) Strong 
Stomach (cardia) Strong 
Lung Moderate 
Hematologic Limited 




Brain Not assignable 
Thyroid No effect (Limited) 
Rectal No effect (Limited) 
 
Table 1. The level of evidence linking physical activity with lower of cancer in 2018 according to 
the Physical Activity Guidelines for Americans Advisory Committee (adapted from Patel et al. 
(5)) 
 
From these observational studies, it is clear that physical activity may play an 
important role in preventing cancer. Nevertheless, an important question is begged: 
what kind and amount of physical activity is necessary to reduce cancer risk? The 
World Health Organization recommends that all adults should engage in a regular 
physical activity (6), including at least 150-300 minutes of moderate aerobic 
physical activity, or 75-150 minutes of vigorous activities or an equivalent 
combination of both. In addition, muscle-strengthening activities at moderate 
intensity should be also performed two times per week (6). Actually, it remains 
difficult to determine the precise type, amount and intensity needed to reduce cancer 
risk, due to the lack of studies investigating different type of activity (e.g., resistance 
training), the different methods utilized for physical activity assessment and 
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classification (5). However, the current amount of aerobic physical activity is 
considered protective against cancer (5). 
 
 
PHYSICAL ACTIVITY AND CANCER SURVIVORSHIP 
 
Physical activity and exercise may be an attractive strategy to adopt in the cancer 
setting. Over the past two decades, several studies have investigated physical 
activity and exercise as an adjunct therapy in cancer patients. Observational studies 
have examined the relationship between pre-diagnosis, post-diagnosis of physical 
activity and mortality among cancer patients (5). Considering the physical activity 
at pre-diagnosis, highest levels was linked to an 18% lower breast cancer and 23% 
lower colorectal cancer mortality risk, while the reduction of overall mortality 
ranged between 13%-25% for breast, colorectal and prostate cancer patients (5). 
After a cancer diagnosis, physical activity is confirmed a potential approach able to 
decrease the risk of overall-mortality (ranging from 21% to 45%) and cancer 
specific mortality (ranging from 26% to 69%), especially in breast, colorectal and 
prostate cancer. 
Exercise is a safe and feasible approach in cancer patients, connected with 
significant enhancements in symptoms-related outcomes (e.g. cardiorespiratory 
fitness, muscle strength) as well as those patient-reported (e.g. fatigue, quality of 
life) (7). Indeed, exercise acts on health-related skills improving cardiorespiratory 
fitness (8), muscular strength and mass (9), which are prognostic factors in cancer 
(10). Randomized controlled trials, as well as reviews and meta-analysis, confirm 
that exercise training is safe and tolerable by the patients, able to prevent and/or 
mitigate the adverse physiological and psychosocial effects of cancer and its 
treatments (11, 12). Specifically, exercise can alleviate some treatment-related 
adverse events, such as fatigue, anxiety and depression levels, lymphoedema, as 
well as preserving bone health, sleep quality, cognitive function, diminishing the 
cardiotoxic risk and the chemotherapy-induced peripheral neuropathy (7). 
Preclinical in vivo studies report that exercise can inhibit tumor growth across a 
wide range of cancer type, although not all the investigation confirm it (13). Several 
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factors have been proposed to modulate cellular processes and tumor growth. On 
one side, host-related factors, such as adiposity, sex-steroid, metabolic and sex 
hormones and immune-inflammatory axis, oxidative stress, have been proposed as 
potential mechanisms susceptible to be regulate by exercise (13). Moreover, 
exercise may impact the tumor microenvironment, through managing tumor 
hypoxia, controlling angiogenesis, tumor cell metabolism and antitumor immune 
phenotype (14). Hence, being physically active may be considered one of the most 
important steps for cancer treatment and control.  
On the basis of the available evidence, different national societies have proposed 
cancer-specific exercise guidelines for use of exercise during and following the 
completion of the therapies (7, 15, 16). In 2019, the last update of the American 
College of Sports Medicine has defined the exercise prescription, conformed to the 
FITT (frequency, intensity, time, type), for each outcomes showing sufficiently 
evidence of improving by exercise (Table 2.) (7). Collectively, an effective exercise 
prescription should comprise 30 minutes of aerobic moderate-intensity at least three 
times per week and resistance training, two times per week, using at least two sets 
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Nevertheless, not all patients meet the exercise guidelines. Wong and colleagues, 
in a systematic review including a total of 10,530 participants, found a large 
heterogeneity in the percentage of patients resulting sufficiently active, ranging 
from 16% to 88% (17). 
Making exercise a standard in cancer care requires a series of considerations to 
translate the research in “exercise oncology” into real world practice. Tailor 
exercise on cancer patients is crucial to increase adherence and maintenance over 
time of an active lifestyle (10). Cancer patients may encounter a series of obstacles, 
potentially interfering with exercise. Some of them could be related to cancer and 
its treatments, such as pain, neuropathy and joint stiffness, other could be more 
general like lack of time or interest (10). Contrarywise, understand patients 
preferences about different issues of exercise programs, as well as apply models 
(e.g., social cognitive theory, theory of planned behavior, and self-determination 
theory) is important to increase patients motivation and to answer to their needs 
(10). However, exercise program should be evidence-based, thus based on the 
aforementioned guidelines for example. It necessary consider that the minimum 
levels of exercise proposed by the guidelines, could be difficult to achieve, 
especially for physically deconditioned patients. Reasonably, an exercise program 
should be flexible, start easily and progressively increasing, according to patient’s 
rhythm and body response. Besides, an heterogeneity in physical, psychological 
status, and treatment-related side effects needs to be considered (10). According to 
available evidence, an accurate baseline assessment, including clinical, physical, 
and psychosocial conditions, is fundamental to schedule a tailored exercise 
program. Recognizing the presence of relevant comorbidities to adapt activity and 
avoid potential exercise-induced risks is fundamental (10). The presence of extreme 
fatigue or high physical limitation could be a contraindication to start an exercise 
program, or a low cardiorespiratory fitness may suggest performing exercise with 
low intensity and for short time. Considering all these factors, in clinical practice 
close collaboration among oncologists and kinesiologists (or cancer exercise 
specialists or physiotherapists) may allow developing specific exercise programs 






Figure 1. Tailored exercise program: a proposed model (adapted from Avancini et al. (10))  
 
However, addressing this issue broadly, a series of stakeholders should be involved 
to enhance the development of exercise oncology, including oncology clinicians, 
healthcare providers, policy makers, researchers, educators, non-profit associations 
and fitness industry, with the aim to create a network to refer patients (18).  
 
 
MULTIDISCIPLINARITY OF SUPPORTIVE CARE IN CANCER 
 
A multidisciplinary approach is largely utilized in cancer care, in which different 
specialists (e.g., medical oncologists, surgeons, radiotherapists, pathologists) 
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collaborate closely to achieve the best possible results for the patient. A similar 
parallelism may be formulated for the supportive care in cancer. Indeed, exercise 
may be a piece of a larger intervention, including a series of experts, e.g., dietitians, 
psychologists, social workers, to offer the best possible therapeutic approach to 
cancer. On one hand, these non-pharmacological interventions may help improve 
quality of life, physical functions, psychological aspects, and treatment-related 
adverse events and reduce symptoms and complications occurring during cancer 
care. Over the years the literature is moving towards the use of multidisciplinary 
and multimodal approach in the cancer setting. For instance, the Enhanced 
Recovery After Surgery (ERAS®) Society, has developed a series of consensus 
statements and guidelines to improve the quality of surgical care (19). These 
guidelines are becoming targeted for specific surgical procedures, identifying the 
most appropriate interventions for preoperative, intraoperative and postoperative 
care (19).  
A common topic emerging from available experiences explores the potential 
synergistic impact of strongly integrated interdisciplinary approaches, 
encompassing coordinated exercise, nutritional, and psychological and behavioral 
interventions. From a theoretical standpoint, it is reasonable to speculate that 
behavioral and psychological intervention or counseling may reinforce motivation 
and compliance, thus potentially favoring adherence to tailored exercise programs. 
On the other hand, nutritional counseling may help to counteract sarcopenia and 
muscle wasting, thereby rendering exercise more effective in maintaining muscle 
mass and improving strength. Indeed, a meta-analysis showed that combined 
exercise and psychological intervention is more effective than a pharmacological 
approach to counteract fatigue (20). Similarly, an integrated approach 
encompassing exercise, dietary guidance, social counseling, and a smoking 
cessation program clearly improved quality of life, emotional well-being, and 
mental health, while reducing anxiety, depression, and distress (21).  
Overall, exercise may be administered as part of a multidimensional, comprehensive 





OVERVIEW AND AIMS OF THE DISSERTATION 
In Italy, the literature about physical activity and exercise in cancer patients is still 
scarce, with only few available investigations. 
Some case reports have been reported, especially on breast cancer (22, 23). De Luca 
et al. conducted a randomized controlled trial in 20 breast cancer patients who 
concluded all cancer treatments at least six months before. After 24 weeks of 
combined aerobic and strength training program, significant improvements in 
cardiorespiratory fitness, strength, quality of life, and body composition were found 
(24). Rispoli and colleagues have investigated the prehabilitative role of exercise in 
lung cancer patients candidate for lobectomy. Four weeks of aerobic and strength 
exercises were efficacious in increasing forced expiratory volume in one second, 
functional capacity, and diminishing the postoperative complications, only in 
patients who performed at least three sessions per week (25). 
However, the scarcity of research in the exercise oncology field reflects another 
problem, i.e., the lack of awareness and dissemination of exercise programs 
specifically dedicated to cancer patients. In Italy, sporadic initiatives to support 
exercise in cancer patients exist often addressed to breast cancer. There is the need 
to implement the study of exercise oncology, on the one hand, to expand the 
knowledge in a country as Italy still lacking, and on the other to begin supporting 
the diffusion of exercise oncology culture on the principal stakeholders (patients, 
clinicians, nurse, etc.).  
The purpose of this dissertation is to increase the research about exercise in 
oncology in Italy.  
The first part of the dissertation comprises four papers and is concerned about the 
implementation of exercise in the cancer context. Paper 1 examines the exercise 
level and preferences in Italian cancer patients. Paper 2 qualitatively investigates 
the barriers and cues to action to exercise in cancer patients. Paper 3 is based on the 
results of Paper 1 and 2 and consisted of the protocol of an interventional study, 
currently ongoing and tailored to cancer patients. Unfortunately, the outbreak of 
COVID-19 has disrupted and slowed down our trial. Nevertheless, this emergency, 
composed of social distancing, closure of several services (gym included), brought 
out the necessity to adapt the exercise programs. In this sense, Paper 4, a 
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commentary about physical activity in cancer patients during the COVID-19 
pandemic, attempts to suggest a series of proposals to develop and perform remote 
exercise programs. 
The second part of the dissertation is composed of two papers. It is about the 
possibility to utilize a multidisciplinary intervention, including pharmacologic 
agents, exercise, nutrition, and psychological support, to improve and/or manage 
cancer-related cachexia. Paper 5 is a special report examining the current state of 
the art in cancer cachexia. Paper 6 is a case report investigating the effect of 
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Background: Despite the benefits related to physical exercise, large numbers of 
cancer patients are not sufficiently active. Methods: To investigate exercise levels 
and preferences in cancer patients, a cross-sectional study was conducted on a 
random sample of 392 cancer outpatients who anonymously completed a 
questionnaire investigating general and medical characteristics and expressed 
willingness to participate in exercise programs. Current exercise levels were 
estimated with the Leisure Score Index (LSI). Results: Most patients (93%) were 
insufficiently active but 80% declared an interest in exercise programs. Patients 
preferred oncologist-instructed programs and specified particular exercise needs. 
Multivariate logistic regression showed that willingness to exercise was associated 
with education (OR: 1.87; 95% CI: 1.15-3.04 beyond age 14 years vs. up to 14 
years) and current physical activity (OR: 1.92; 95% CI: 1.92-3.63 for sweat-
inducing activity >2 times/week vs. <1 time/week). Patients given chemotherapy 
were less inclined to exercise (OR: 0.45; 95% CI: 0.23-0.86) than those who did 
not. LSI was lower if cancer stage was advanced (β: -0.36; 95% CI: -0.75 to -0.02) 
than if it was in remission. High LSI was also associated with longer education, 
lower BMI, and longer time after diagnosis. Conclusion: Cancer patients are 
insufficiently active but are willing to participate in personalized exercise 
programs. Information from this survey may help in designing personalized 






In 2019 it was estimated that about 3.5 million Italians (5.3% of the entire 
population) are living after a cancer diagnosis (26). Improvements in medical 
treatments have led to a substantial increase in the proportion of cancer patients 
with death rates similar to those of the general Italian population (27). 
Cancer and its treatments are associated with various side effects that negatively 
affect the patient's quality of life for a long time after the conclusion of therapies 
(28, 29). There is growing evidence that in cancer patients (especially breast, colon 
and prostate) (30-32) an active lifestyle is associated with a lower risk of recurrence 
and mortality. Physical activity (PA) refers to any bodily movement produced by 
skeletal muscles that requires energy expenditure (33). Exercise is defined as a 
subcategory of PA, consisting of structured, planned and repetitive movement (33). 
Exercise was shown to be safe and feasible in oncological settings (11) and several 
studies found that exercise improved patients' quality of life during (34, 35) and 
after treatment (35). Positive effects of exercise include increasing 
cardiorespiratory fitness (8) and muscular strength (36), and improvement in body 
composition (36). Additionally, exercise helped regulate several side effects of 
cancer treatment, such as fatigue (37), and nausea (38),  and improved the 
psychological status, for instance, reducing levels of anxiety and depression (39).  
Despite the benefits related to PA and exercise a large percentage of cancer patients 
from 25% to 84% - are not sufficiently active (17, 40, 41) and the level of exercise 
has been seen to decrease after cancer diagnosis (42). A multitude of factors 
influence the participation of the general population in exercise programs (e.g. lack 
of time, cost, logistic difficulties, etc.) (43). Cancer patients face further obstacles 
on account of their condition (e.g. cancer-related fatigue, muscle weakness, nausea, 
sleep disorders) (44, 45). To develop a successful exercise intervention, cancer 
patients’ barriers and preferences must be considered, allowing them to pick the 
activities they perceive as beneficial and enjoyable (45-48). International studies 
investigated the preferences and determinants of exercise levels in cancer patients 
and survivors (40, 49-55), but data on the Italian population are lacking. 
Furthermore, cultural differences in this area might be significant. In order to  
overcome this information gap the STIP-ON (Sustainable training in pazienti 
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oncologici) survey was designed with the following aims: i) To understand the size 
of the problem, i.e.: to calculate the prevalence of insufficient exercise among 
cancer patients; ii) to analyze the patients’ characteristics associated with 
insufficient exercise; iii) to analyze the patients’ characteristics associated with 
their motivation/willingness to take part in a future intervention program on 
exercise; iiii) to describe patients’ preferences about exercise. 
The rationale of the study is that understanding patients’ preferences and barriers to 
physical activity will make it easier for them to participate successfully in a future 
intervention study to improve their physical fitness. 
 
Materials and Methods 
Study design and participants 
This STIP-ON study is a cross-sectional survey. Data was collected and recorded 
anonymously from patients visiting the cancer outpatients' facilities at the Oncology 
Unit of “Azienda Ospedaliera Universitaria Integrata”, University of Verona, 
Verona, Italy between July 2018 and April 2019.  Cancer patients' eligibility criteria 
were: age ≥18 years, a cancer diagnosis and adequate Italian language proficiency 
to answer the survey questionnaire (QEX). Invited participants included all kinds 
of cancer survivors (including those whose diagnosis had just been made or was 
being defined). The STIP-ON sample was thought to be representative of patients 
visiting the cancer outpatients' facilities: on randomly selected days they were 
approached face to face, informed about the study and asked whether they would 
be willing to complete the questionnaire anonymously to investigate their 
characteristics and preferences regarding exercise.  Invited participants were 
systematically asked by the staff if they had already completed the survey another 
time/day before this QEX was administered.  A duplicate check was done, looking 
for duplicates by date of birth, province of residence, sex, education, and marital 
status. If interested in participating, patients were asked to give signed informed 
consent, and received a leaflet (Supplementary Material 1) describing the purpose 
of the study and a copy of QEX. QEX was completed on the spot or could be taken 
home and returned within a week. In both cases participants were asked to leave the 
completed QEX anonymously in a special ‘ballot box’.  
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The project was reviewed and approved by the Ethics Committee for Clinical Trials 
(Prot. No. 49018), University of Verona. All study procedures were conducted 
following the last revision of the declaration of Helsinki as well as the declaration 
of Oviedo. The study protocol was designed to adhere to Good Clinical Practice 
principles and procedures and had to comply with Italian legislation. 
 
 The survey questionnaire (QEX) 
The QEX is a self-administered survey to collect cancer patients' preferences and 
characteristics associated with exercise. The questionnaire is the result of a co-
design process that involved patients (via patients' associations) and experts, 
including oncologists, kinesiologists, epidemiologists and psycho-oncologists. The 
pilot version of QEX was developed based on a literature review (49-53) made 
available to these ‘reviewers’ to give feedbacks and make an unofficial peer review 
to develop the current version. While QEX is a self-reported, anonymous survey, 
staff support (including dedicated personnel in the room) was available during the 
survey to address any questions. The QEX comprises 31 items (Q1 - Q31), divided 
into four sections: a) General characteristics (from Q1 to Q9); b) Physical exercise 
level (from Q10 to Q11); c) Physical exercise preferences (from Q12 to Q26); d) 
Cancer diagnosis and treatment (from Q27 to Q31). A copy of QEX is available 
online as Supplementary Material 2. 
 
Questions 1-9: General characteristics  
The following demographic, anthropometric and socio-economic characteristics of 
patients are collected in the QEX: birth date (day, month, year), sex, province of 
residence, education level (elementary (up to age 10-11 years)/ secondary-up to 14 
years/ secondary-up to 18-19 years/college-university /postgraduate), marital status 
(single/married/divorced/widowed, occupational status (retired/homemaker/part-
time employed/full-time employed/ other), perceived economic adequacy 
(inadequate/barely adequate/adequate/more than adequate), body weight (kg) and 
height (cm) (both continuous). Age was calculated by subtracting the date of birth 
from the date of QEX compilation and classified in two categories (<65; ≥65y). 
Body mass index (BMI) was calculated from the weight in kilograms divided by 
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the height in meters squared (kg/m2). BMI categories were defined as follows: 
underweight (BMI <18.5 kg/m2), normal weight (BMI 18.5-24.9 kg/m2); 
overweight (BMI 25-29.9 kg/m2); obese (>29.9 kg/m2) (56). 
 
Questions 10-11: Level of physical exercise  
The QEX inquiry about current exercise level was based on questions from the 
Godin Leisure-Time Exercise Questionnaire (GLTEQ) (57, 58) which is widely 
used for cancer patients (58). A detailed description of the computation of LSI from 
GLTEQ is found elsewhere (57, 58). In brief: i) The GLTEQ enquires about the 
previous week’s leisure time frequency (times/week) of vigorous, moderate and 
mild intensity exercise; ii) Each exercise intensity is associated with the metabolic 
equivalent of the task (MET): MET = 9 for vigorous, MET = 5 for moderate, MET 
= 3 for mild intensity exercise (57); iii) The LSI is then calculated as the sum of 
(vigorous * 9) + (moderate * 5) per-week exercise frequency according to Godin 
and Shepard (57). Based on their LSI, patients are classified as active (if LSI ≥24) 
or insufficiently active (if LSI <24) according to the 2010 release of American 
College of Sports Medicine (ACSM) Exercise Guidelines for cancer patients (59). 
The ACSM guidelines suggest cancer patients engage in at least 150 minutes/week 
of moderate or 75 minutes/week of vigorous exercise (59). The QEX includes an 
additional self-rated question about the frequency (times/week) of sweat-inducing 
activity. There are three categories of frequency (often/sometime /never-rarely) 
These questions and categorization are also taken from GLTEQ (57). 
 
Questions 12-26: Physical exercise preferences 
Exercise preferences were investigated by questions from previous studies (49-53). 
The first question concerns the patient's willingness to participate in an exercise 
program (yes/no/maybe).  Respondents were asked about their preference 
regarding: who would give them exercise instructions (oncologist/nurse/ 
kinesiologist/nutritionist/physiotherapist/another cancer patient/no preference/ 
other); how to receive exercise instructions (face to face/by telephone/videotape/ 
television/brochure-pamphlet/over the internet/no preference/other); with whom 
they would prefer to exercise (nobody/other cancer patients/family members/ 
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friends/a group/no preference/other); where (at home/at a community fitness 
center/at an adapted exercise fitness center/outside/no preference/other); what time 
of day (morning/afternoon/evening/no preference); what part of the week 
(weekday/weekend/no preference) and how often (from never to seven 
times/week). Further information was collected on preferred intensity 
(mild/moderate/ strenuous/no preference), session content variability (same each 
time/different each time/no preference), “helper” during the program 
(nobody/exercise specialist/ neighbor/colleague/friend/son-daughter/spouse/other 
relative), supervision (unsupervised/ supervised/no preference) and kind of exercise 
program (individual with a program to follow at home/individual with personal 
trainer/in a group with a kinesiologist/physiotherapist/exercise specialist). There 
were also two open-ended questions in which respondents were encouraged to list 
the top three preferred exercise activities in winter and summer. 
 
Questions 27-31: Cancer diagnosis and treatment 
Medical variables were self-reported by patients and included: tumor site (lung/ 
colorectal/breast/head-neck/upper gastrointestinal/ gynecological/ urogenital/ 
melanoma/ hematological/ other), disease status (unknown/in remission-cured/ 
early/advanced/metastatic), date of diagnosis (month/year), type of treatment 
(surgery/chemotherapy/ radiotherapy/hormone therapy/ other) and current 
treatment status (about to start/ ongoing/ completed/not known). 
Time from diagnosis was calculated by subtracting the date of diagnosis from the 
date of QEX compilation and was classified in two categories using the median 
(≤30 months; >30 months). 
 
Statistical analysis  
Descriptive analyses are presented as mean, medians and IQR for continuous 
variables and frequencies and percentages for categorical variables. Categorical 
non-ordinal variables were incorporated as dummy variables (Xd) in regression 
models so that Xd=1 if the condition is true and Xd=0 if not. Minimally adjusted 
models to investigate patients' characteristics associated with willingness to 
participate and current exercise level included age and sex as explanatory variables. 
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Multivariable regression models to investigate patients' characteristics associated 
with their willingness to participate and current exercise level included explanatory 
variables, selected in advance, in the fiducial model that subsequently maximized 
the goodness of fit, according to the Akaike information criterion (AIC) (60).These 
variables included: sex, age, education, residence, perceived income adequacy, 
marital status, occupational status, frequency of sweat-inducing activity, tumor site, 
disease, chemotherapy, surgery, radiotherapy, hormone therapy, other treatments, 
treatment status, time from diagnosis, “lack of preference” (score 0 for no no-
preference reply, score 1 for 1 no-preference reply, score 2 for 2 or more no-
preference replies to exercise preference questions), “independence” (score 0 if “on 
my own” never chosen in exercise preference questions, score 1 otherwise.  
The sample size of 200 cancer patients was based on the feasibility criteria of the 
study. The expected sample allowed estimates of binary variables [e.g. percentages 
of active (p) vs. percentages of insufficiently active (P=1-p) or percentages of 
patients expressing interest vs. percentages expressing no strong interest] with a 
standard error of 0.035 and a confidence interval between 0.43 and 0.57, assuming 
the most unfavorable proportion equal to 0.5 (P=0.5) and alpha 5%. 
Statistical tests were two-sided and p values <0.05 were considered significant. The 
Stata statistical package, version 14 (Stata Corp, Texas, USA) was used. 
 
Results 
The flow diagram of participants is shown in Figure 1. Among the 694 patients 
approached, 249 (36%) declined to participate in the survey. The most frequent 
reason for declining was lack of interest. Among the 445 who agreed to participate, 
53 did not return the QEX, leaving the final study sample of 392 subjects (55% of 


































▪ Lack of interest (183) 
▪ Physical difficulties (17) 
▪ Lack of time (14) 
▪ Not useful (4) 
▪ Not physically active (14) 
▪ Other reasons (17) 
Approached (694) 
(cancer patients approached)  
Accepted (445; 64%)  
(agreed to participate) 
Completed survey (392; 55%) 
(returned the questionnaire) 
Survey not completed (53) 




General and tumor characteristics 
Demographic and medical variables stratified by the willingness to participate in 
the exercise program are set out in Table 1. The participants’ mean age was 
59.6±12.2 y, 61% were female, 69% were married and 61% had at least higher 
education, up to age 18-19 years. Overall, 83% of participants were still on active 
treatment; the most frequent tumor sites were upper gastro-intestine (42%) and 
breast (26%), with a mean time from diagnosis of 2.4 years. 
 
Table 1. General and tumor characteristics of 392 cancer patients† according 
to willingness to participate in a specifically designed exercise program. 
  Willingness to participate‡ 
P-
value§ 
 All Yes Maybe No 
 (392) (179) (134) (79) 
 No. % No. % No. % No. 
Age (years)         
< 65 239 48 115 38 91 14 33 0.023 
 ≥ 65 149 42 63 28 41 30 45 
Sex         
Female 238 51 121 32 77 17 40 0.023 
 Male 154 38 58 37 57 25 39 
Province of 
residence  
        
Verona 244 43 105 34 82 23 57 0.114 
 Other  148 50 74 35 52 15 22 
Education         
Elementary  
(up to 10-11 years) 
32 28 9 28 9 44 14 0.002 
Secondary 
 (up to 14 years)  
119 41 49 37 44 22 26 0.451 
Secondary  
(up to 18-19 years)  
162 50 80 36 59 14 22 0.031 
College/University 52 54 28 25 13 21 11 0.308 
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Postgraduate  18 50 9 33 6 17 3 0.920 
Body Mass Index          
Underweight 19 58 11 32 6 11 2 0.455 
Normal weight 228 46 104 34 78 20 46 0.994 
Overweight 107 41 44 36 39 22 24 0.503 
Obese 30 57 17 27 8 17 5 0.461 
Marital status         
Single  51 43 22 35 18 22 11 0.903 
Married 269 45 122 35 94 20 53 0.819 
Divorced 35 46 16 34 12 20 7 0.999 
Widowed  34 56 19 24 8 21 7 0.371 
Occupational 
status 
        
Retired 161 46 74 30 48 24 39 0.151 
Homemaker  43 44 19 30 13 26 11 0.622 
Part-time 
employed 
45 49 22 42 19 9 4 0.118 
Full-time 
employed 
123 46 57 38 47 15 19 0.242 
Other 20 35 7 35 7 30 6 0.462 
Perceived income 
adequacy†† 
        
Inadequate  28 50 14 36 10 14 4 0.746 
Barely adequate  120 45 54 40 48 15 18 0.152 
Adequate  180 44 80 34 61 22 39 0.676 
More than 
adequate  
61 51 31 23 14 26 16 0.103 
Exercise level‡‡         
Insufficiently 
active 
363 45 162 35 127 20 75 0.338 
Active 27 59 16 26 7 15 4 
Tumor site         
Breast 101 54 55 31 31 15 15 0.096 
Lung 22 41 9 36 8 23 5 0.894 
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Colorectum 39 31 12 49 19 21 8 0.091 
Head/neck 9 44 4 22 2 33 3 0.554 
Upper gastro-
intestine 
166 46 77 35 58 19 31 0.821 
Gynecological 8 50 4 38 3 13 1 0.862 
Urogenital 19 53 10 21 4 26 5 0.450 
Melanoma 14 21 3 29 4 50 7 0.015 
Other 14 36 5 36 5 29 4 0.659 
Disease status         
Unknown 53 40 21 32 17 28 15 0.274 
In remission/cured 62 56 35 27 17 16 10 0.178 
Early 86 48 41 37 32 15 13 0.411 
Advanced 85 38 32 40 34 22 19 0.239 
Metastatic 106 47 50 32 34 21 22 0.866 
Treatments §§         
Surgery 215 44 95 32 69 24 51 0.167 
Chemotherapy 329 44 144 36 119 20 66 0.102 
Radiation therapy 113 44 50 29 33 27 30 0.119 
Hormone therapy 50 56 28 30 15 14 7 0.249 
Other  27 59 16 19 5 22 6 0.190 
Treatment status         
About to start 11 55 6 27 3 18 2 0.829 
Ongoing 325 44 144 35 115 20 66 0.452 
Completed  35 51 18 29 10 20 7 0.728 
Unknown 21 52 11 29 6 19 4 0.804 
Time from 
diagnosis 
21 52 11 29 6 19 4 0.804 
≤30 months 178 48 86 37 65 15 27 0.080 
 ≥30 months 214 43 93 32 69 24 52 
† Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019. ‡ 
Willingness to participate in exercise program assessed by the question: Would you be interested in 
participating in an exercise program designed for cancer patients? § Pearson's chi-squared used the 
null hypotheses of no association between physical exercise level and other patient/disease 
characteristics. ¶ Body Mass Index categories are those of the World Health Organization (56). 
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††Perceived income adequacy assessed by the question: Does your monthly income cover your 
monthly expenditure? ‡‡ Exercise level according to Leisure Score Index (LSI). Patients are active 
if LSI ≥24 and insufficiently active if LSI <24 (58). §§ Treatments, which may be completed or in 
course, and are not mutually exclusive. 
Exercise behavior  
Details on participants' exercise behavior by sex and age are shown in Table 2. 
Patients reported mean frequencies of strenuous, moderate and mild exercise of 0.2 
± 0.84; 0.71 ± 1.43 and 1.56 ± 2.15 times/week respectively. The LSI found 93% 
of patients insufficiently active, and only 7% met physical activity 
recommendations [33]. Men and women reported similar exercise behavior through 
age. Older patients (≥65 years) reported a decline in strenuous and moderate 
exercise frequencies and an increase in mild exercise compared to <65 years.
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Table 2. Characteristics of preceding week’s exercise in cancer patients† by age and sex. 
 
All patients Age <65years  Age ≥65years 
(392) Men (81) Women (158) Men (71) Women (78) 
Exercise frequency 




















































































           
Exercise level††   N % N % N % N % N % 
Insufficiently active  363 93 76 94 144 92 66 94 74 95 
Sufficiently active 27 7 5 6 13 8 4 6 4 5 
Sweat-inducing activity‡  N % N % N % N % N % 
Often  60 16 9 11 23 15 15 21 13 17 
Sometimes  121 32 28 35 54 35 16 23 21 27 
Rarely/never   204 53 43 54 77 50 39 56 43 56 
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† Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019. ‡ Exercise intensity according to (57). § SD, standard deviation.  




Participants exercise preferences are listed in Table 3. Overall, 80% of the 
respondents were willing (i.e. yes or maybe) to participate in an exercise program 
designed for cancer patients. Over half (57%) preferred to receive exercise 
instructions from an oncologist, about 30% from a physiotherapist and 20% from a 
kinesiologist. The preferred way to receive exercise instructions was with a face-
to-face approach (72%), followed by no preferences (12%). The people they 
preferred to exercise with were other cancer patients (27%). The favorite place for 
exercise was outside (27%), followed by an adapted exercise fitness center (22%) 
or at home (21%). Almost half (48%) indicated they preferred exercising in the 
morning and 70% preferred exercising during a weekday. Just over a third (37%) 
opted to exercise twice a week and another 30% three times a week. Walking, 
swimming and biking were the favored activities in summer, while in winter 
participants opted for walking, gym-training and swimming. Participants also 
specified that they preferred training at mild (48%) or moderate (39%) intensity. 
About 34% of patients preferred exercise sessions to vary. Most of them (62%) 
preferred supervised exercise. The preferred helpers were spouses (28%), exercise 
specialists (22%) or friends (19%).  The preferred exercise program was in a group 
with an expert (40%).  
 
Table 3. Exercise preferences in cancer patients †. 
Preference as expressed by answers to questions % No. 
Are you interested in participating in an exercise program designed 
for cancer patients? (392) 
  
Yes 46 179 
No 20 79 
Maybe 34 134 
Who would you prefer to receive exercise instructions from? (392) ‡   
Oncologist 57 224 
Nurse 7 26 
Kinesiologist 20 80 
Nutritionist 20 80 
Physiotherapist 30 118 
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Another cancer patient 3 11 
No preference 20 79 
Other 2 8 
How would you prefer to receive exercise instructions? (376)   
Face to face 72 270 
By telephone 3 13 
Videotape 2 9 
Television 1 3 
Leaflet/pamphlet 5 20 
Over the internet 3 13 
No preference 12 46 
Other 1 2 
 Where would you prefer to exercise? (378)   
At home 21 78 
At a community fitness center 12 44 
At an adapted exercise fitness center 22 83 
Outside  27 103 
No preference 18 70 
Other 1 2 
What time of day would you prefer to exercise? (376)   
Morning 48 179 
Afternoon  31 118 
Evening 9 32 
No preference 13 48 
In what part of the week would you prefer to exercise? (367)   
Weekday 70 256 
Weekend 9 32 
No preference 22 79 
How would you prefer to exercise? (363)   
Unsupervised 15 56 
Supervised 62 224 
No preference 23 83 
 What kind of exercise program would you prefer? (360)   
Individual with a program to follow at home 27 96 
Individual with personal trainer 25 90 
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In a group with a kinesiologist/physiotherapist/exercise specialist 40 144 
Other  8 30 
Would you like session content to vary? (363)   
Same each time 29 105 
Different each time 34 123 
No preference 37 135 
Who would you prefer to exercise with? (373)   
Nobody  16 61 
Other cancer patients 27 104 
Family members 8 29 
Friends 8 30 
A group  13 47 
No preference 27 101 
Other 1.3 5 
Who would you want as “helper” during the program? (369)   
Nobody 13 48 
Exercise specialist 22 83 
Neighbor 1 5 
Colleague 1 3 
Friend 19 71 
Son/daughter 13 47 
Spouse 28 102 
Other relative 3 10 
How often would you prefer to exercise?  (365)   
Never 1 5 
Once a week 15 54 
Twice a week 37 136 
Three times a week  30 111 
Four times a week 5 19 
Five times a week 5 19 
Six times a week 1 5 
Seven times a week 4 16 
What exercise intensity would you prefer? (376)   
Mild 48 175 
Moderate 39 141 
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Strenuous  7 24 
No preference 6 23 
† Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019 ‡ 
Replies add up to more than 694 as participants could choose more than one instructor. 
 
Relations between demographic/medical variables within exercise behavior and 
willingness to participate in exercise program 
Table 4 shows the relations between characteristics of cancer patients willing to 
participate the exercise program. Multivariable logistic regression models showed 
that these patients most likely attended at least secondary school beyond age 14 
years (OR=1.87, 95% CI = 1.15 to 3.04) and had more than double the sweat-
inducing activity per week (OR=1.92, 95% CI = 1.92 to 3.63). Among medical 
treatments, patients who received chemotherapy were less willing to participate 
(OR=0.45, 95% CI=0.23 to 0.86) than those who did not. 
Table 5 shows how patients’ characteristics were related to current exercise levels. 
Levels was lower in patients with BMI ≥25 (β=-0.33, 95% CI -0.57 to -0.10) than 
those with BMI <25.  Exercise levels were higher in patients who had attended at 
least secondary school beyond age 14 years (β=0.32, 95% CI 0.09 to 0.55) 
compared with those with less than secondary school. Patients who self-defined 
their disease stage as "advanced" had lower exercise levels (β -0.36, 95% CI -0.75 
to -0.02) than those in remission/cured.  
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Table 4. Multivariable logistic modeling of associations of characteristics of cancer patients † with willingness ‡ to 







Minimally-adjusted model§ Fully-adjusted model¶ 
OR †† 95% CI †† P-value†† OR†† 95% CI †† P-value†† 
Age  
≤ 65 y (reference) 239 115 1   1   
≥ 65y 149 63 0.84 0.55; 1.28 0.424 0.63 0.34; 1.15 0.085 
Sex  
Women (reference) 238 121 1   1   
Men 154 58 0.61 0.40; 0.93 0.021 0.55 0.32; 0.94 0.029 
Education 
Up to age 14 years 
(reference) 
151 58 1   1   
Beyond age 14 years  241 121 1.60 1.04; 2.46 0.031 1.87 1.15; 3.04 0.011 
Residence  
Outside city (Reference) 148 74 1   1   
In Verona  244 105 0.70 0.46; 1.07 0.100 0.61 0.38; 0.99 0.045 
Perceived income 
adequacy  
Inadequate (reference) 148 68 1   1   
Adequate 244 111 1.06 0.69; 1.61 0.764 0.94 0.58; 1.51 0.785 
Marital status  
Married (reference) 269 122 1   1   
Single 51 22 0.77 0.41; 1.44 
0.366 
0.64 0.31; 1.31 
0.213 Divorced 35 16 0.92 0.45; 1.89 0.94 0.43; 2.01 
Widowed  34 19 1.88 0.85; 4.16 2.51 1.04; 6.04 





Homemaker  43 19 0.66 0.31; 1.33 
0.354 
0.73 0.33; 1.61 
0.203 
Part-time employed 45 22 0.83 0.37; 1.62 0.67 0.30; 1.50 
Full-time employed 123 57 0.83 0.46; 1.43 0.68 0.36; 1.29 




<1 time/week (reference) 204 84 1   1   
1-2 times/week 121 61 1.46 0.92; 2.32 
0.037 
1.50 0.91; 2.25 
0.035 
>2 times/week 60 33 1.79 1.00; 3.23 1.92 1.92; 3.63 
Tumor site§§, ¶¶ 
Breast (reference) 101 55 1   1   
Lung 22 9 0.60 0.24; 1.58 
0.251 
0.52 0.16; 1.68 
0.423 
Colorectal  39 12 0.39 0.18; 0.86 0.46 0.18; 1.16 
Upper gastro-intestine   166 77 0.73 0.44; 1.20 0.62 0.31; 1.24 
Urogenital system  19 10 1.00 0.37; 2.75 1.02 0.28; 3.67 
Melanoma 14 3 0.23 0.06; 0.88 0.13 0.03; 0.64 
Other sites6 31 13 0.66 0.29; 1.51 0.52 0.20; 1.40 
Disease status 
Remission (reference) 62 35 1   1   
Early 86 41 0.70 0.36; 1.36 
0.145 
0.61 0.27; 1.37 
0.595 
Advanced 85 32 0.48 0.25; 0.95 0.65 0.29; 1.44 
Metastatic 106 50 0.71 0.37; 1.44 0.72 0.30; 1.73 
Unknown 53 21 0.51 0.24; 1.08 0.83 0.33; 2.06 
Chemotherapy 
No (reference) 55 31 1   1   
Yes 329 144 0.51 0.28; 0.92 0.026 0.45 0.23; 0.86 0.016 
Surgery   No (reference) 169 80 1   1   
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Yes 215 95 0.91 0.60; 1.37 0.644 1.07 0.67; 1.71 0.787 
Radiotherapy 
No (reference) 271 125       
Yes 113 50 0.90 0.57; 1.41 0.650 0.97 0.58; 1.61 0.900 
Hormone therapy 
No (reference) 334 147       
Yes 50 28 1.45 0.78; 2.71 0.239 1.66 0.83; 3.32 0.152 
Other treatments 
No (reference) 365 163       
Yes 27 16 2.10 0.92; 4.82 0.077 1.89 0.81; 4.39 0.142 
Treatment status 
Completed (reference)  36 18 1   1   
About to start 11 6 1.46 0.36; 5.84 
0.695 
1.80 0.31; 10.5 
0.781 Ongoing 325 144 0.79 0.37; 1.60 0.75 0.33; 1.71 
Unknown 21 11 1.27 0.42; 3.83 1.72 0.45; 6.48 
Time from 
diagnosis 
≤ 30 months (reference)  178 86 1   1   
> 30 months  214 93 0.79 0.53; 1.19 0.265 0.68 0.42; 1.13 0.126 
† Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019 ‡ Willingness classified as yes vs. no/maybe. § Age- and 
sex- adjusted models, unless otherwise specified. ¶ Each variable adjusted for the following, unless otherwise specified: Sex (man vs. woman); 
Age (<65 y vs.  ≥65 y); Education (more than 14 years of age vs. up to 14 years); Residence (outside city vs. win city of Verona); Perceived 
income adequacy (adequate vs. inadequate); Marital status (married, single, divorced, widowed); Occupational status (retired, homemaker, part-
time employed, full-time employed, other); Frequency of sweat-inducing activity (<1 time/week, 1-2 times/week, >2 times/week); Tumor site 
(breast, lung, colorectum, upper gastro-intestine, urogenital system, melanoma, other); Disease status (in remission, early, advanced, metastatic, 
unknown); Chemotherapy (yes vs. no); Surgery (yes vs. no); Radiotherapy (yes vs. no); Hormone therapy (yes vs. no); Other treatments (yes vs. 
no); Treatment status (Completed, About to start, Ongoing, Unknown); Time from diagnosis (≤30 months, >30 months); “Lack of preference” 
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variable (score 0 for no no-preference reply, score 1 for 1 no-preference reply, score 2 for 2 or more no-preference replies given to exercise 
preference questions); “Independence” variable (score 0 if “on my own” never chosen in exercise preference questions, score1 otherwise.  †† OR 
(odds ratios), CI (confidence intervals), and P-values from multivariable logistic regression model. §§ Tumor sites with less than 10 patients are 




















Table 5. Multivariable regression modeling of associations of characteristics of 392 cancer patients † with exercise level ‡. 
   Exercise level† Minimally-adjusted model § Fully-adjusted model ¶ 




β†† 95% CI †† 
P value 
†† 
Age  <65 y (reference) 238 0.61 1.14 Ref   Ref   
 ≥65y 148 0.42 0.91 -0.17 -0.39; 0.05 0.125 0.03 -0.24; 0.31 0.801 
Sex  Female (reference) 237 0.58 1.10 Ref   Ref   
 Male 153 0.46 0.99 - 0.10 -0.32; 0.12 0.378 - 0.08 -0.32; 0.16 0.489 
Body Mass Index 
(kg/m2) 
 <25 (reference) 245 0.67 1.21 Ref   Ref   
≥25 137 0.31 0.71 - 0.34 -0.57; - 0.11 0.003 - 0.33 -0.57; - 0.10 0.005 
Education 
Up to age 14 years 
(reference) 
149 0.32 0.75 Ref   Ref   
Beyond age 14 years  241 0.67 1.19 0.32 0.10; 0.55 0.004 0.32 0.09; 0.55 0.005 
Perceived income 
adequacy   
Inadequate (reference) 147 0.52 1.14 Ref   Ref   
Adequate 243 0.55 1.01 0.06 -0.16; 0.28 0.581 0.03 -0.20; 0.25 0.826 
Marital status  
Married (reference) 275 0.53 1.00 Ref   Ref   
Single/other 51 0.63 1.15 0.04 -0.28; 0.37 
0.86 
- 0.05 -0.39; 0.28 
0.781 Divorced 35 0.63 1.52 0.08 -0.30; 0.46 0.01 -0.37; 0.39 
Widowed 34 0.41 0.90 -0.06 -0.46; 0.34 - 0.07 -0.47; 0.34 
Occupation Retired (reference) 160 0.38 0.83 Ref   Ref   
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Homemaker  43 0.40 0.87 -0.05 -0.42; 0.33 
0.048 
0.02 -0.37; 0.41 
0.073 
Part-time employed 45 0.66 1.14 0.19 -0.14; 0.62 0.24 -0.16; 0.64 
Full-time employed 123 0.76 1.34 0.37 0.07; 0.66 0.32 -0.01; 0.62 
Other 19 0.38 0.74 -0.01 -0.53; 0.51 0.09 -0.48; 0.66 
Tumor site ‡‡  
Breast (reference) 101 0.63 1.27 Ref   Ref   
Lung 22 0.09 0.33 -0.49 -0.97; 0.02 
0.579 
-0.52 -1.05; 0.01 
0.926 
Colorectum  39 0.32 0.94 -0.30 -0.67; 0.12 -0.33 -0.76; 0.10 
Upper gastro-intestine   164 0.59 1.02 -0.02 -0.29; 0.24 -0.03 -0.36; 0.31 
Urogenital system 19 0.39 0.94 -0.18 -0.70; 0.35 -0.26 -0.82; 0.31 
Melanoma 14 0.79 1.10 0.17 -0.43; 0.76 0.04 -0.61; 0.68 
Other site §§ 31 0.53 0.92 -0.15 -0.51; 0.34 -0.18 -0.65; 0.30 
Disease status 
Remission (reference) 62 0.85 1.25 Ref   Ref   
Early 85 0.73 1.31 -0.10 -0.44; 0.25 
0.006 
0.15 -0.24; 0.54 
0.010 
Advanced 84 0.30 0.82 -0.51 -0.86; -0.15 -0.36 -0.75; -0.02 
Metastatic 106 0.50 0.97 -0.30 -0.63; 0.03 -0.28 -0.59; 0.08 
Unknown 53 0.31 0.69 -0.49 -0.87; -0.10 -0.43 -0.81; 0.03 
Chemotherapy 
No (reference) 55 0.56 1.05 Ref   Ref   
Yes 327 0.54 1.07 -0.06 0.36; 0.25 0.720 0.04 -0.34; 0.38 0.914 
Surgery   
No (reference) 167 0.48 0.98 Ref   Ref   
Yes 215 0.58 1.12 0.10 -0.12; 0.31 0.366 0.07 -0.16; 0.31 0.540 
Radiotherapy 
No (reference) 269 0.55 1.10 Ref   Ref   




No (reference) 332 0.53 1.07 Ref   Ref   
Yes 50 0.58 1.00 -0.01 -0.34; 0.32 0.955 0.10 -0.26; 0.46 0.581 
Other treatments 
No (reference) 363 0.53 1.05 Ref   Ref   
Yes 27 0.60 1.10 0.09 -0.33; 0.51 0.682 0.10 -0.37; 0.57 0.684 
Treatment status 
Completed (reference)  35 0.83 1.31 Ref   Ref   
About to start  11 0.54 1.62 -0.20 -0.93; 0.53 
0.184 
0.18 -0.67; 1.04 
0.462 Ongoing 323 0.50 1.00 -0.30 -0.67; 0.07 -0.14 -0.54; 0.26 
Unknown 21 0.54 1.08 -0.21 -0.79; 0.37 -0.08 -0.72; 0.55 
Time from 
diagnosis 
≤30 months (reference)  177 0.47 0.94 Ref   Ref   
>30 months  213 0.59 1.15 0.13 -0.08; 0.34 0.225 0.15 -0.08; 0.39 0.207 
† Participants of STIP-ON study conducted  in Verona, Italy, from July 2018 to April 2019 ‡ Exercise level assessed using Leisure Score Index 
(58). § Age and sex adjusted models unless otherwise specified. ¶ Each variable was adjusted for the following, unless otherwise specified: Sex 
(man vs. woman); Age (<65y vs. ≥65y); Education (beyond 14 years of age vs. up to 14 years); Residence (outside city vs. in city of Verona); 
Perceived income adequacy (adequate vs. inadequate); Marital status (married, single, divorced, widow); Occupational status (retired, homemaker, 
part-time employed, full-time employed, other); Tumor site (breast, lung, colorectum, upper gastro-intestine, urogenital system, melanoma, other); 
Disease status (remission, early, advanced, metastatic, unknown); Chemotherapy (yes vs. no); Surgery (yes vs. no); Radiotherapy (yes vs. no); 
Hormone therapy (yes vs. no); Other treatments (yes vs. no); Treatment status (completed, about to start, ongoing, unknown); Time from diagnosis 
(≤30 months vs. 30 months). †† Beta coefficients 9(β), confidence intervals (CI), and P values from multivariable regression models. The β 
coefficient is the amount of change in exercise level (Leisure Score Index) in each category of predictor variable compared to reference.  ‡‡ 





The STIP-ON survey found that only 7% of cancer patients do enough physical 
exercise. Previous studies reported the percentage of cancer patients with adequate 
exercise levels, between 16-85% (17). Considering the impact of physical inactivity 
on the quantity (30-32) and quality (34, 35) of life in cancer patients this is an 
alarming result. 
Roughly 80% of patients were willing to start an exercise program designed for 
cancer patients. Previous studies reported similar results, finding that the majority 
of bladder (61), non-Hodgkin’s lymphoma (51), prostate (49), head and neck (53), 
endometrial (50), ovarian (52) and breast (49) cancer survivors were interested in 
an exercise program. This is important because it supports the cancer patients’ 
desire for an exercise service. 
Several socio-demographic characteristics were associated with the willingness to 
participate in an exercise program. Willingness decreased with age, also in fully 
adjusted models, and this was to be expected given the growing difficulties and 
comorbidities due to aging. Age has been associated with low adherence to exercise 
in cancer patients in various studies (52, 62). What is interesting is that even among 
the older patients more than two thirds said they might be interested in taking part 
in an exercise program. Women were more willing to participate than men. That 
was found in all models, even after adjustment for medical and socio-demographic 
variables. That women cancer patients adhere better than men in exercise programs 
is suggested by an intervention study in rectal cancer patients (62) although a 
systematic review evaluating the predictors of adherence to exercise interventions 
during cancer treatment suggested that adherence was best among men (63). Better 
educated patients were more willing to participate. This was reported in other 
studies too (52, 64) and a likely explanation is well-educated people’s greater 
awareness and knowledge of the benefits of exercise. It is interesting that economic 
security was not related to the willingness to participate, and that too was suggested 
by other studies (62). This lack of association might be the result of two 
concomitant and opposing phenomena: those who have less financial availability 
willingly accept a free offer to exercise; the same poorer people, however, may have 
less desire to exercise because they are less motivated or because they do manual 
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work. Patients who reported higher frequencies of sweat-inducing activity were 
more willing to participate in an exercise program that those less frequently 
reporting it. This can be summed up with the Italian saying: "it rains where it’s 
already wet": in other words, those who are most motivated are those who would 
need it less. No similar results were found in the literature, but a possible 
explanation is that those who have already done more physical exercise perceive 
the benefits better and are therefore more ready to improve or increase their level 
(65). Chemotherapy was inversely associated with the willingness to participate. 
There is one study that found no relation between cancer treatment and adherence 
in high-intensity and low-to-moderate intensity exercises (64); other studies found 
chemotherapy (63) and its side effects (44) were associated with low adherence to 
physical exercise programs. One explanation for these contradictory results may be 
that chemotherapy is a generic term that includes different drugs and various 
possible side effects. There were no differences in willingness to participate based 
on other medical variables, and this is consistent with previous work on this topic 
(52). 
Regarding the preferred source of exercise instruction, the oncologist was the 
preferred person to deliver instructions in the present survey and this is not in line 
with the current standard of care. Previous investigations reported an exercise 
expert (kinesiologist) as the favorite (17). Findings from the present survey may be 
related to the lack of exercise specialists for patients at the Verona Hospital 
Oncology Unit. The trusting relationship between the patient and the oncologist 
built up during the cancer journey is another likely explanation. Less than half of 
oncologists promote exercise with their patients (66). Barriers that interfere with 
exercise promotion by oncologists were identified as lack of time, limited access to 
an exercise specialist/program and lack of knowledge about exercise in cancer (67). 
However, educational sessions about exercise in cancer patients and caregivers, 
specific education materials (leaflets, brochures, posters ,etc.) and/or a kinesiologist 
as part of the clinical team are recognized factors to help promote exercise (67). 
Social support plays a role in exercise program compliance (68). In the oncological 
setting, social support enhances emotional well-being (69) and is related to PA 
engagement (70). The present results are in line with this: 55% of patients preferred 
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exercise with others (cancer patients, relatives, friends); about 87% expressed 
interest in having a helper, i.e. a person to help and motivate them with the exercise, 
identifying various subjects: the spouse or other relatives, or exercise specialists. 
Social support from different helpers has been seen to be effective for behavior 
change (71): family, friends, peers, exercise specialists, healthcare providers, and 
other influential subjects might be the key figures to support compliance and the 
maintenance of exercise over time (72). 
Although in previous studies there was a marked preference for a home-based 
program (17, 49, 50, 52, 61), in this study similar percentages of patients preferred 
exercising outside, or in an adapted exercise fitness center, or at home. This 
suggests that providing different program options would boost compliance for 
exercise interventions. To reinforce this assumption, subjects were asked what they 
would choose out of three exercise options (individually with a program to follow 
at home/individually in a gym with a kinesiologist/in a group class with a 
kinesiologist/none of these). More than 90% indicated their preference among these 
options. 
The majority of STIP-ON participants preferred a supervised exercise program. 
This finding contrasts with studies on bladder (61), head and neck (53), prostate 
and breast (49) cancer, but is in line with other investigations on mixed (73), lung 
(74) and endometrial (50) cancers. One explanation might be related to the patients’ 
health condition: cancer-related treatments affect normal physical function and 
influence daily activities, hence the need for supervision from a qualified figure to 
avoid adverse effects. Moreover, supervised exercise intervention may give 
additional benefits for cancer patients. A recent metanalysis including a total of 
4,519 patients with mixed cancer types evaluated the effect of exercise on quality 
of life and physical function; it found twice the effect size for supervised compared 
to unsupervised training (75). 
In line with previous studies (49, 50, 52, 53, 61, 73), a substantial proportion of 
patients indicated walking as their favorite activity, in winter and summer. Walking 
programs have been effective to manage treatment side effects and improve 
physical functions in cancer populations (76, 77). Walking is relatively safe, 
flexible and easy as it does not require special skills (78). Moreover, walking can 
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be done in different environmental situations, is accessible and appropriate in 
groups of different age, sex, ethnicity, education or income levels, and does not 
require expensive equipment. Walking is also known to reduce social barriers 
among people of different socio-economics status (79). 
Contrary to other reports (49, 50, 53, 73, 74), the present study indicated the 
preferred exercise intensity as mild. Exercise guidelines for cancer patients suggest 
they should engage in at least moderate exercise (7). Mild intensity could be the 
choice to start an exercise program, especially with physically ‘deconditioned’ 
people, and should be gradually increased to moderate and vigorous intensity. 
Several reviews show moderate-to-vigorous but not mild exercise intensity is 
effective in managing cancer side effects, and improves physical function (37, 80).  
In light of this evidence the present findings highlight the need to inform cancer 
patients and their caregivers about the safety of moderate and vigorous intensities 
exercise.  Patients' exercise levels were related to their educational level, type of 
treatment and body fatness. Several studies have investigated the determinants and 
triggers of exercise behaviors in patients, but with inconsistent findings (81-83). 
This appears to be the first study investigating the determinants of exercise 
preferences in Italian cancer patients before they were involved in exercise 
intervention programs. The study results provide useful data for planning future 
exercise programs. The self-reported QEX permitted the collection of a large 
amount of data and was quickly administered, without much burden on respondents, 
or costs. Another point of strength is the collection of information about why 
individuals did not wish to take part in the study.  
Limitations of the study need to be noted: the QEX information was self-reported 
and therefore open to several sources of bias. The QEX was filled and returned 
anonymously, so social desirability bias (for instance, patients may exaggerate their 
physical activity so as not to ‘disappoint’ the researcher) is less likely. The 
information leaflet given to patients at recruitment provides minimal information 
presenting the study but does not contain any recommendations/ guidelines.  
However, just having provided information might have influenced the replies. 
Another potential source of error is selection bias: cancer patients who agreed to 
participate in the survey may be individuals more interested in exercise. To ensure 
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a representative sample of patients, a random sample of outpatients was selected. 
Finally, the questionnaire does not serve to classify exercise adherence according 
to the new ACSM (7) guidelines for cancer patients. These guidelines were released 
in October 2019, after the QEX had been administered to the study sample of 
patients (7). Nevertheless, the QEX classifies patients according to the previous 
ACSM guidelines (59). This allows us to compare patients’ exercise levels with the 
studies that have been reported so far. Classification of the LSI according to the 
ACSM guidelines for cancer patients (59) allows a full comparison of study finding 
with the majority of other studies in the field. Nevertheless, this classification may 
have artificially inflated the percentage of participants who reported insufficient 
physical activity. The QEX does not collect information about participants’ pre-
diagnosis exercise and physical activity and that limit its ability to explore 
associations with other possible determinants of current exercise behavior. The 
patients in STIP-ON were sampled to be representative of those attending the 
Verona oncology clinic (and not the full total of patients). Therefore, although more 
severe patients with severe comorbidities are likely to have been excluded, patients’ 
responses may also have been influenced by other comorbidities that were not 
investigated by the QEX. 
Information from this survey is clinically relevant and may help in designing 
personalized interventions so cancer patients will achieve sufficient exercise/PA. 
Here are a few examples: i) Since about 90% of participants said they wanted or 
needed a helper during the program, a targeted intervention program should include 
specific activities (and support) for helpers patients will nominate; ii) Because about 
30% of respondents said they prefer to exercise with other patients, exercise classes 
specifically for them and "learning from peers" social occasions should be 
organized; iii) The majority of patients were insufficiently active and preferred mild 
exercise or slow walking. So as not to leave anyone behind, for those who are not 
able to engage in moderate exercise, a mild flexible entry program should be offered 
according the patient’s condition and preferences and then progress slowly towards 
higher-intensity exercise. 
In conclusion, an exploratory survey like STIP-ON could serve as a necessary first 
step in developing lifestyle improvement interventions for patients. This is 
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particularly important in a country like Italy where there is little knowledge in this 
field, and factors such as the family environment and social support are not well 
understood. Only a small proportion of patients were sufficiently active, although 
the majority were willing to start an exercise program. Exercise preferences in 
cancer patients tended to vary substantially. These findings underline the urgency 
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Introduction: Although the literature supports the importance of physical activity 
in oncological context, in Italy a large number of patients are not sufficiently active. 
Methods: The present study aimed to explore factors influencing an active lifestyle 
in cancer patients during oncological treatments. Semi-structured focus groups, 
including 18 patients with different cancer types, were conducted at the Oncology 
Unit in the University Hospital Trust of Verona (Italy). The interviews were audio-
recorded, transcribed verbatim, and analyzed with content analysis.  Results: 
According to the Health Belief Model, transcripts were categorized into the 
following themes: benefits, barriers, and cues to action. Patients reported a series 
of physical, physiological, and psychological benefits deriving from an active 
lifestyle. The main barriers hampering the physical activity participation were 
represented by treatments-related side effects, advanced disease, and some medical 
procedures, e.g., ileostomy. Several strategies that can trigger patients to exercise 
were identified. Medical advice, social support from family and friends, features as 
enjoyment, setting goals, and owning an animal can motivate patients to perform 
physical activity. At the same time, an individualized program based on patients' 
characteristics, an available physical activity specialist to consult, more detailed 
information regarding physical activity in the oncological setting, and have 
accessible structures, were found important facilitators to implementing an active 
behavior.  Conclusions: Overall, patients have a positive view regarding physical 
activity, and a variety of obstacles and cues to action were recognized. Considering 
these information may help to improve adherence to a physical activity program 





Cancer is the second leading cause of mortality in Italy (26), and it is expected an 
increase in cases and deaths between 2018 to 2040, by 22% and 35%, respectively 
(84). Oncological patients usually receive several integrated and multimodal 
therapies that may damage patients ‘integrity, harming their quality of life (7). The 
cancer treatment-related side effects are usually cumulative and consequently may 
entail a progressive impairment of both the physical and psychological status in 
patients (85). 
Physical activity has emerged as an important complementary supportive care for 
cancer patients (7). Evidence suggests a positive outcome in terms of reduction of 
recurrence and mortality risks (5) and amelioration of several treatment-related side 
effects, such as nausea, vomiting, peripheral neuropathy, fatigue, arthralgia, or 
myalgia (12). From a physical and psychological point of view, physical activity is 
associated with an increase in cardiorespiratory fitness (8), muscular strength (9), 
and an improvement in body composition (9), quality of life (75), anxiety (7), and 
depression levels (7). Despite the benefits, in Italy, only 7% of cancer patients 
appears to be sufficiently active (86). 
Numerous aspects can interfere or contrarywise facilitate patients to adopt an active 
lifestyle during cancer treatments. Some of these are in common with the general 
population (e.g., weather, lack of time), whereas others are strictly related to the 
disease history (45).  Also the attitude, i.e., the perception of a behavior as positive 
or negative, can affect the intention and the maintenance of physical activity 
performance, also in the oncological context (87). Developing a physical activity 
program that considers these features may increase the compliance and the 
maintenance over time of an active lifestyle by the patients. Unfortunately, in Italy, 
the literature on physical activity and cancer is still limited, with no clear data 
regarding the adherence to a physical activity program (24). Although several 
investigations have explored attitude, barriers, motivators, and facilitators, able to 
influence the adoption of physical activity in oncological settings (46, 47, 88-96), 
no data on Italian patients are available. In order to fill this gap and to successfully 
design a future interventional study, we have qualitatively explored those factors 
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influencing the adoption of an active lifestyle in cancer patients visiting the 




This study applied a qualitative approach, through a series of focus groups, to assess 
the factors influencing physical activity behavior in the cancer setting. This study 
applied a qualitative approach, through a series of focus groups, to assess the factors 
influencing physical activity behavior in the cancer setting. The theoretical 
framework driving the investigation was the Health Belief Model, postulating that 
health-related practice, especially related to disease conditions, is influenced by 
several factors, including susceptibility and seriousness of the disease, perceived 
benefits, and barriers towards a behavior, cues to action, and self-efficacy (97). 
Because this study was related to health promoting factors, rather than to 
perceptions of severity or vulnerability to peculiar conditions, it focused on patients' 
perceptions of the benefits of physical activity, barriers to engagement, and cues to 
action that would promote physical activity. 
All the study procedures were conducted in compliance with Helsinki and Oviedo 
declaration, and the protocol adhered to Good Clinical Practice principles and 
Italian legislation. The project was reviewed and approved by the local Ethics 
Committee for Clinical Trials (Prot. N. 67002), University of Verona. It was carried 
out following the Standards for Reporting Qualitative Research (SRQR) guidelines 
for qualitative research (98). 
 
Participants and recruitment 
We recruited participants that met the following criteria: (i) were ≥ 18 years of age, 
(ii) had a confirmed cancer diagnosis, (iii) were currently patients at the outpatient 
Department of Oncology in the University Hospital Trust of Verona (Italy), (iv) 
spoke fluently Italian and (v) signed the informed consent. No exclusion criteria 
were applied. A purposive sample strategy was used to recruit patients. The 
participants were identified by the dedicated psycho-oncologist, DT, working at the 
Oncology Department of University Hospital Trust of Verona. With a face to face 
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approach, the psycho-oncologist introduced the study to the patients, and if they 
agreed to participate, the interviews were organized. Written informed consent was 
obtained from included patients the day of the interviews before starting the focus 




To explore the factors that influence the physical activity behavior in cancer setting, 
a flexible semi-structured interview guide, based on the Health Belief Model (97), 
was developed by AA, DT, and ML. Between September 2019 and February 2020, 
five focus groups (n=4, 4, 4, 3, and 3) were held in a meeting room at the Oncology 
Department in University Hospital Trust of Verona. Each discussion lasted up 
approximately 70 minutes, was audio-recorded and transcribed verbatim. The last 
author (ML) moderated the discussions; meanwhile, AA and LR observed and 
assisted. ML is an Associate Professor in Sports Science and Methodology at 
Verona University with expertise in physical activity and health promotion. AA is 
a Ph.D. student involved in exercise in oncological patients, with previous interview 
experiences, and LR is a master's degree student in preventive and adapted physical 
activity. The sample size was established using the data saturation principle, i.e., 
data collection continued until no new information seemed to emerge from the 
discussions. At the end of each focus group, participants completed a questionnaire 
to provide information about their socioeconomic and demographic data (e.g., birth 
date, education level, perceived economic insecurity, marital status, and 
occupational status). Patients' medical history was obtained by medical charts. 
 
Analysis 
The data were analyzed with the Atlas.tiTM software, using the content analysis (99). 
This process comprised some essential steps and involved AA, LR, and ML, that 
independently examined the transcripts. The investigators read and re-read the 
entire text several times to get a general idea of the discussion and identify the 
salient concepts. Subsequently, the analysis process consisted of inductively coding 
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the features relevant to the research questions. Then, the codes were grouped into 
categories and organized in themes (99). 
Finally, all three authors reviewed the analysis in a process called triangulation, 
which consisted in comparing the codes, the categories, arriving to a consensus on 




Participants and demographics 
A total of 36 patients were screened for eligibility. During the recruitment 18 
patients have declined to participate, due to: unavailability in the proposed days 
(n=11), worsening in health conditions (n=5), and lack of interest (n=2). Five focus 
groups with a total of 18 participants, after the discussion among researchers, have 
permitted to achieve the data saturation. 
Demographic and medical variables were reported in Table 1.  
 
Table 1. Participants' characteristics. 
Variable  
Agea, mean (SD) 55,2 (10,3) 
Body mass indexb, mean (SD) 23,7 (3,0) 
Education, N  
Secondary (up to 14 years) 5 
Secondary (up to 18-19 years) 8 
College/University 4 
Postgraduate  1 




Employment, N  
Part-time employed 4 
Full time employed 9 
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Retired  4 
Unemployed 1 
Family incomec, N   
Barely adequate 8 
Adequate 9 
More than adequate 1 
Met physical activity guidelines (90+ min/week), N  
Yes 10 
No 8 






Head and neck 1 
Melanoma 1 
Thymus 1 





Months from diagnosis, mean (SD) 25,7 (16,5) 
Treatment, N  
Surgery 10 
Chemotherapy 17 
Radiation therapy 8 
Hormone therapy 5 
Immunotherapy 3 
Target therapy 3 






Comorbidity, N  
Yes  10 
No  8 
Legend: SD, standard deviation, N, number;  
a Expressed in years; b Expressed in units of kg/m2; c Perceived economic insecurity assessed by 
the question: Does your monthly income cover your monthly expenditure?  
 
The mean age of the participants was 55.2 ± 10.3 y, 16 were married, 13 had at least 
higher education, up to age 18-19. All participants were on active treatment; the 
most frequent cancer sites were upper gastro-intestinal (n=6) and breast (n=6), with 
a mean time from diagnosis of 25.7 months. The data were analyzed according to 
the Health Belief Model (Figure 1), and the following common themes were 




Figure 1. Health Belief Model theoretical framework applied to physical activity 




According to these findings, a series of recommendations to promote a successful 




Figure 2. Strategies to implement a physical activity program in the oncological 
clinical setting 
 
Theme 1: Benefits 
This theme reflected the belief of the patients regarding physical activity and was 
grouped into two main categories: (a) physical and physiological benefits, and (b) 
socio-psychological benefits. 
 
a) Physical and physiological benefits 
All patients strongly expressed that physical activity is beneficial for overall well-
being. The positive effects of being physically active were related to physical 
aspects, as Arianna (breast) told: "Physical activity has a beneficial impact on my 
body, also during the chemotherapy treatment: I have more strength, I can maintain 
my muscle mass and I am in a good mood". Some subjects also recognized the 
impact of physical activity to counteract treatments related side-effects: "I suffered 
from constipation due to cancer therapies, and walking has been very beneficial for 
me against this disorder" (Tiziana, breast) or "I usually go running before my 
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chemotherapy, and I do not experience any treatment-related side effects, while, if 
I do not, I feel exhausted, I have nausea and vomiting" (Matteo, pancreas). Finally, 
a patient underlined how to be active can help to fight cancer: "Physical activity 
keeps the estrogens at low levels. My cancer eats estrogens, so if I do physical 
activity, I starve my tumor" (Tiziana, breast).  
 
b) Socio-psychological benefits 
Participants identified several advantages related to psychological aspects: "When 
you perform physical activity, endorphins are released. This mechanism can help 
to fight the depression…and consequently to have a different attitude in 
approaching cancer" (Maria pancreas). Physical activity was described as a 
"natural recharge", "(Physical activity) makes you feel good, especially from the 
mental point of view…you feel charged and ready to face everything" (Martina, 
breast), and, as a "day organizer", "(Physical activity) can really help you to plan 
your daytime, and even if something unexpected happens, you are able to manage 
it" (Salvatore, pancreas). Moreover, patients expressed that physical activity was a 
vehicle to increase their perception of control, in the cancer context, as Martina 
(breast) told, "when you suffer from cancer, you rely on the oncologists, surgeons, 
nurses, etc.; physical activity is something that you decide to do! You can take the 
reins of the situation and control it without being at the mercy of the events". The 
subjects also recognized how to be physically active can help them to face the 
cancer disease also in the family context: "When I go walking with my husband, we 
talk about everything, we plan, and we organize our next steps; physical activity 
has truly reunited us, despite my cancer" (Maria, pancreas). 
 
Theme 2: Barriers 
Many factors were individuated as potential barriers, which can hinder physical 
activity. Obstacles were grouped into three categories: (a) lack of motivation, (b) 
disease condition, medical treatments and risk of injury, and (c) weather, expenses, 
lack of time, and information. 
 
a) Lack of motivation 
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Lack of motivation, emerged as the self-described "laziness", was the central 
concept reported about less than half of participants. "I am the perfect example of 
laziness. I do not like physical activity even if I recognize its importance", said Luca 
(thymus), or "Physical activity is secondary for me…my head tells me that it is 
important, but I am lazy" (Elisa, breast). However, some of them recognized their 
predisposition and consequently tried to react positively, as Teresa (colorectal) 
expressed: "I am lazy, and I know it. Thus, I put myself in situations that force me 
to be physically active". 
 
b) Disease condition, medical treatments and risk of injury 
Health conditions and cancer treatment-related side effects were identified as the 
major barriers to physical activity. Chemotherapy side-effects can impact on the 
ability to perform a regular physical activity, as Martina (breast) said "When you 
are undergoing cancer treatments, sometimes you are not able to get up from the 
sofa; neither with your willpower, you can!", or Debora (pancreas) explained, "This 
chemotherapy malaise, expressed especially with fatigue, leads you to do less 
physical activity". The presence of bone metastasis was identified a significant 
limitation to exercising, as Elisa (breast) expressed, "I have bone metastasis in the 
spine, and I know that I must avoid loading in that zone" or Michele (lung) 
elucidated, "I love cycling, but I cannot perform it because I have hip bone 
metastasis. I am on fracture risk, and I am afraid to get injured". Patients indicated 
some medical procedures that interfere with their physical activity. The presence of 
ileostomy was emerged as an obstacle, seriously limiting the daily physical activity: 
"I have an ileostomy, which has generated a hernia; before I was able to walk for 
10 kilometers, but now I can make only one or one and a half. Furthermore, I cannot 
do some activities, such as swimming, because I have a bag in my belly" (Maria, 
pancreas). Also, the central venous catheter (CVC), can impair the perception to be 
able to perform physical activity: "I have a psychological block regard the presence 
of CVC. I know that I could do physical activity without realizing to have the CVC, 
but this is a huge psychological obstacle for me" (Luca, thymus). Some concerns 
were emerged about the risk of injury: "When I go walking, I experience back pain 
sometimes" Elisa (breast), or "You could get hurt, like injure your knee" Martina 
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(breast). During the discussions, also the excess of physical activity, as a potentially 
harmful factor have been mentioned: "Exaggeration could potentially be 
dangerous" Luca (thymus), or "One time I overdid, and the day after I was sick, I 
felt confused," expressed Matteo (pancreas). 
 
c) Weather, expenses, lack of time and information 
Rain, seasonality, or more, in general, extreme weather, can interfere with physical 
activity: "Weather is an obstacle, because if the downpour falls you prefer to stay 
at home" (Michele, lung), or "I am in crisis during the winter season, due to cold 
and little sunlight" (Sergio, head and neck). On the contrary, also heat can impede 
the physical activity predisposition: "I do not like performing physical activity 
during the summer, it is too hot; I feel exhausted" (Alessandro, melanoma). A 
common factor identified by the patients was the lack of information regarding 
physical activity in the oncological setting: "It is hard to find suitable information 
regarding physical activity" (Martina, breast) or "I have an exercise bike at home, 
but I do not know if it is beneficial for me to load my hips or my knees; I do not have 
information about this" (Ennio, pancreas). Lack of time was an obstacle prevalently 
emerged in patients that were still working: "Between family and work, it is really 
difficult to find some time to dedicate in exercising" (Sergio, head and neck). 
Finally, one subject expressed some concerns about the cost related to physical 
activity: "I would like to try archery, but is too expensive, 500 euros for three 
lessons. It seems that some sports are only for a small elite group of people" (Luca, 
thymus). 
 
Theme 3: Cues to action 
Seven categories grouped the stimuli that trigger the decision-making process to 
perform physical activity:  (a) counseling, social support (b) enjoyment, goals, and 
pets, (c) targeted physical activity programs, (d) an available specialist, (e) 
supporting information, and (f) organizational aspects. 
 
a) Counseling and social support 
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Interpersonal factors were important to motive patients to start physical activity. On 
the one side, the initial advice of oncologists or other relevant figures was a 
considerable incentive to be physically active, as Alessandro (colorectum) 
mentioned, "Talking with doctors can really help you to start exercising," or 
Daniela (breast) said "When I started my chemotherapy, my physical and 
psychological status were bad. After the advice of medical staff, I began walking, 
and I bought a cyclo-ergometer". On the other side, another aspect regarded strong 
support from family and friends. "My son calls me 100 times per day to remind me 
to stay active…my strength derives from my sons because they tell me that I am a 
wonder woman; they give me so much energy" said Debora (pancreas) or "I 
appreciate that my husband come walking with me because I usually do not take 
many initiatives alone" specified Marta (ovary). About the friends' support, 
Alessandro (melanoma) declared: "My friends stimulate me to restart cycling with 
them, they are a positive support for me!". 
 
b) Enjoyment, goals, and pets 
Patients referred to be positively encouraged if they set goals, or a targeted 
objective, as Gigliola (breast) said, "During my cancer therapies I gained weight, 
so I decided to begin physical activity with the aim to improve my body composition. 
Since January, I have lost 10 kilograms!". Some participants reported enjoyment as 
an incentive to perform physical activity: "I love walking; it is a positive activity! 
Maybe I could have started it before!" (Marta, ovary) or "Be physically active gives 
you great satisfaction. I like it" (Matteo, pancreas). A patient reported that having 
a pet can help to maintain an active lifestyle: "Having a dog helps you stay active 
because you must get it out every day, even when the weather is bad" (Alessandro, 
melanoma). 
 
c) Targeted physical activity programs 
A targeted, flexible program was identified as a key facilitator by the patients. 
Almost half of the patients reported that physical activity should be programmed at 
the beginning of cancer treatments, as Marta (ovary) explained: "…when you start 
chemotherapy, you do not think about physical activity. It should be programmed 
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at the beginning, after diagnosis, and included in the therapeutic plan". Different 
preferences have emerged regarding the modality to perform physical activity: "I 
want (exercising) alone" (Michele, lung) or "Due to work, family and other reason 
I would prefer training at home, but with monthly counseling with a physical 
activity specialist" Sergio (head and neck) or "I like to do physical activity in-group, 
with other patients" Salvatore (pancreas). All the participants agreed that a physical 
activity program should be targeted on the patient's disease and the comorbidities: 
"The activity should be diversified according to the different type of disease; I have 
had breast surgery with axillary dissection, and some exercises may be better for 
me but not for those patients that experienced another type of cancer" Martina 
(breast)  or "I have a herniated disc so the activity should be adequate also to my 
comorbidity" Salvatore (pancreas). 
 
d) An available specialist  
Several subjects have expressed the necessity to have a qualified specialist inside 
the Oncology Unit. Although the initial advice by medical staff can encourage 
subjects to start physical activity, some patients desired more specific instructions: 
"When I received the diagnosis, I asked the oncologists: what do I do? Should I 
perform physical activity? They usually answered me: do what you feel like 
doing…but this kind of response is not satisfying!" Salvatore (pancreas). From their 
perspectives, an available specialist could strongly help them to be more self-
confident in performing physical activity: "Now the only activity that I perform is 
walking, because I am afraid of getting injured. I must be cautious due to my bone 
metastases. In my opinion, having a qualified specialist inside the hospital would 
give me more confidence" Arianna (breast) or "When you are diagnosed with 
cancer, you do not know whom to ask information. It is helpful to have in the same 
place oncologist, dietitian, psychologist, surgeon, etc., so even for the physical 
activity could be the same" Martina (breast). 
 
e) Supporting information  
Promote physical activity, through credible and suitable information, including the 
benefits and practical consideration to exercising, can facilitate the engagement: 
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"Promoting the information regarding the benefits of physical activity, specifying 
the advantages for the body systems and your disease" Ennio (pancreas) and "I need 
information about how to perform physical activity because I am 60 years old and 
I do not think to begin to do an uphill race" Sergio (head and neck). Participants 
reported the importance of having specific information: "Maybe it would be 
necessary to give patients detailed, and more targeted information, based on the 
type of disease" Maria (pancreas) or " The information should be addressed on the 
key points that specify the benefits of an active lifestyle related to disease because 
this can help to consider physical activity as real medicine." 
 
f) Organizational aspects 
Suitable structures can facilitate an active lifestyle. Some patients would perform 
physical activity outdoor, as Daniela (breast) supported, "I prefer to do physical 
activity outside if the weather is good". Others would desire a gym inside the 
hospital: "In each oncological unit there should be a gym, it is necessary, because 
it is important such as the chemotherapy, and could simplify the approach to 
physical activity" Debora (pancreas). Moreover, another important characteristic 
was the distance from the fitness center: "Having a gym near home is extremely 
important because if I have to drive, I will not go" Gigliola (breast). 
 
Discussion 
The present study explored factors that influence physical activity engagement in 
cancer patients suggests a series of recommendations to promote a successful 
physical activity program in this population (Figure 2.). 
 
Benefits 
We found that patients generally have a positive perception of physical activity, 
reporting a variety of related benefits, from physical factors to those physiological 
and socio-psychological. These results are consistent with previous studies (65, 89-
91, 93, 96). Smith and colleagues reported that patients described physical activity 
as positive behavior for general health, to manage some treatment-related side 
effects and other chronic conditions (e.g., cardiovascular disease) (89). Older breast 
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cancer survivors mentioned that an active lifestyle help to reduce the stress levels 
and combat depression(90). At the same time, Mazzoni et al. found that patients 
exercising during oncological treatments reported a feeling of self-control (65). 
 
Barriers 
Several barriers inhibiting cancer patients’ physical activity participation were 
identified. Some of them are related to cancer and its treatments. These results are 
comparable with previous investigations (88, 89, 92, 94, 95, 100). A recent, 
qualitative meta-synthesis has confirmed that the most relevant obstacles of 
adopting an active lifestyle were linked to cancer- and treatment-related side 
effects(94). Fatigue is one of the most reported impediments which hinder the 
engagement in physical activity in this study, but also other works (89, 93, 100). 
Nevertheless, a recent meta-analysis, including 113 studies with a total of 11,525 
patients, showed that exercise was more effective than pharmaceutical interventions 
to ameliorate the level of cancer-related fatigue (101). To date, it is well 
consolidated the role of physical activity to improve fatigue in cancer so much that 
also the recent ESMO clinical practice guidelines for cancer-related fatigue include 
exercise as an efficacious tool to manage this symptom (102). Thus, inform patients 
regarding the beneficial effect of physical activity on fatigue is crucial. Although 
similar reports reported safety issues, including the risk of injury (93, 94, 100), as 
features hindering physical activity, this appears the first investigation finding bone 
metastasis as a factor, seriously limiting the engagement in physical activity. 
Exercise oncology in advanced cancer is rapidly increasing during recent years. 
Promising results, such as the safety of fracture risk and the preliminary efficacy of 
exercise in patients with bone metastasis (103), were showed, also for resistance 
training, the activity traditionally considered detrimental for fracture risk (104). 
Patients with bone metastasis expressed their will to be active, but also the 
impediment of not knowing which exercises are safe and whom to rely on to 
practice physical activity. In this regard, reassuring patients about safety and adapt 
the activities to their ability should be considered. In line with prior studies (88, 
100), some procedures, as the ileostomy and the CVC were recognized, potential 
obstacles to exercising. Henriksson and colleagues found a similar concern about 
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the peripherally inserted central catheter in patients during adjuvant treatments (88). 
One possible explanation could be, that this type of procedure undermines patients’ 
confidence on their ability, thus doubting of the possibility to perform physical 
activity. Another related concept is just about the available information on physical 
activity. Patients referred to the lack of specific material and suggest that having 
targeted information may facilitate the engagement by the patients. The lack of 
accessible and evidence-based information about physical activity in cancer is a 
persistent problem in the current literature. A recent study reviewed the website in 
the English language that provide information on maintaining or improving 
physical activity after a cancer diagnosis (105). The results showed that the 
importance of physical activity is frequently mentioned, while the available 
information suffer from lack of comprehensive, specific advice as well as detailed 
mention to practice (105). Thus, in this work authors suggested that written or 
online health information to be efficacious should be high quality and accessible, 
evidence-based, should motivate and guide the engagement, outlining the risk and 
advising the seeking of professional advice (105). 
Although not surprising, the presence of obstacles related to external situations 
(e.g., bad weather, expenses, etc.), consistently mentioned in previous works (95, 
106), the lack of motivation, self-described by patients as “laziness”, was not so 
usual. In other investigations(106), (95) patients reported laziness as a feature 
hindering their willingness to exercising, suggesting that planning a physical 
activity intervention aimed also to appropriately build patient’s motivation could be 
an effective way to overcome this state of mind. 
 
Cues to action 
Regarding the cues to action, social support by family and friends motivated 
patients to stay active. However, the literature showed mixed results. On the one 
side, social support was a vehicle to increase the physical activity motivation (89); 
on the other, an investigation found indifferent the relationship with the family and 
others (96). Focusing on counseling, patients reported medical advice as an 
important motivator to support an active lifestyle. A previous work finds that 
patients preferred to receive initial information by their oncologist (86), and a 
73 
 
randomized trial indicated that a 30-seconds oncologist recommendation was able 
to significantly increase exercise levels in breast cancer survivors attending a 
primary adjuvant treatment consultation (107), thus supporting the importance to 
get the endorsement by the oncologist. However, the advice of medical staff can be 
the first step to manage behavior; in our study, having the opportunity to consult a 
physical activity specialist can be encouraging patients to receive a program 
adapted to their necessity and conditions and can consequently stimulate them to 
improve their lifestyle. This agrees with prior investigations (89, 94), and, 
interestingly, also with the oncology care providers' perspectives. Indeed, from the 
medical staff point of view, having a physical activity specialist as part of the 
clinical team and educating patients about physical activity are considered the 
optimal strategies to engage patients in exercising (67).  
Moreover, also enjoyment and setting goals are effective strategies to support 
patients and to increase adherence in a physical activity program and contrast lack 
of motivation. According to the present research, also in the study of Mikkelsen and 
colleagues, patients with advanced cancer reported the importance of enjoyment, 
setting goals, and tracking progress as a strategy to increase motivation (93). 
Interestingly, our work found that having a pet can act as a motivator to promote 
physical activity. To our knowledge, no prior research found a similar result. 
Nevertheless, the use of pet therapy, i.e., offer several activities, using an animal in 
order to maintain both mental and physical human health, is a broader topic, which 
can provide numerous benefits. Contact with pets may reduce loneliness, offering 
security, and giving encouragement. Moreover, a recent systematic review showed 
that animal-assisted interventions in oncology settings have a positive association 
with physiological and psychological outcomes, including oxygen saturation, 
quality of life, perceived satisfaction, and depression, and other negative mood 
states (108). 
Regarding the preferred structures to perform physical activity, the participants 
‘opinions were heterogeneous. For some patients, the program should be delivered 
in the hospital, while for others in a gym near home. This was reported in other 
studies on preferences too (47, 92), and one possible explanation could be that some 
patients, especially with advanced disease, may feel more confident in a hospital 
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setting. Consistent with previous research (106), patients have declared that 
physical activity programs should be tailored according to their cancer type and the 
presence of comorbidities. Moreover, different preferences were found regarding 
the modality to perform the physical activity; some patients preferred to exercise 
individually, others with a program to follow at home, while some choose a group-
based program. This finding supports a survey-research, which found that 40% of 
cancer patients preferred a group-based physical activity program, 25% an 
individual program with a personal trainer, and 27% chose an individual program 
to follow at home (86). Overall, these results suggest that offer different programs, 




Our study had some limitations, including the low response rate, which may have 
introduced a selection bias, even if the main reasons to decline the participation in 
the study did not support this hypothesis. In our investigation, about half of the 
patients met the current exercise guidelines, while literature usually reports low 
physical activity levels in this population (17, 86). Nevertheless, differently from 
previous investigations applying the prior guidelines version, this study has 
followed the recent American College of Sports Medicine guidelines for cancer 
patients, released in October 2019 (7). Therefore, although we cannot exclude that 
our sample was positively biased towards physical activity, we assume that the 
obtained results may at least partially mirror the current situation in general cancer 
population. Moreover, in our study, patients had different cancer types, and 
consequently, the results may not be generalizable. Nevertheless, our research 
aimed to investigate the features that affect the engagement in physical activity in 
a "real world" context of the Oncology Unit. For this reason, we believe that 
including in the sample participants with different socioeconomic status, 
demographic characteristics, and various cancer types was a strength of our 
investigation.  
Finally, in our sample, more than half of the participants were affected by an 
advanced stage disease. In this light, our findings may be partially biased, being 
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more applicable to those patients dealing with more burdensome symptoms and 
treatment issues than those at earlier stages. From the other side, this population is 
usually understudied regarding physical activity predispositions and practice 
supporting the relevance of this data in providing a specific intervention potentially 




In conclusion, physical activity has been demonstrated to represent an essential 
complementary tool in cancer patients. In order to develop a lifestyle intervention, 
exploring factors influencing physical activity behavior is particularly important, 
especially in Italy, where the literature on this field is scarce. Overall, we found that 
patients had positive beliefs, reporting a variety of benefits. The barriers were 
mainly oriented to the disease conditions and treatment-related side effects. 
Nevertheless, several strategies were identified to support and motivate cancer 
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Introduction: Physical activity is associated with reducing mortality risk and 
improvement in quality of life and health-related skills in cancer. Nevertheless, a 
large percentage of Italian cancer patients do not engage in regular exercise. In this 
sense, we have developed the CHOiCE (Choose Health, Oncological patients 
Centered Exercise) trial. Methods: A prospective randomized study will evaluate 
the exercise intervention in 80 patients with mixed cancer types at early stages. 
Exercise will consist of 3-months of bi-weekly training, including aerobic and 
resistance training activities. The aerobic component will comprise cardiovascular 
exercises, progressively increasing from 10 to 30 minutes at moderate intensity, i.e., 
3-5 of the 10-point Borg Rating of the Perceived Exertion Scale (RPE). Resistance 
training components will include six body weight or elastic bands exercises 
performed in 2-3 sets of 8-12 repetitions, at moderate intensity, i.e., 3-5 of the RPE. 
The primary endpoint will be exercise feasibility, defined as recruitment rate, 
adherence, withdrawals, and adverse events. Adverse events will be categorized 
according to the Common Terminology Criteria for Adverse Events. Secondary 
endpoints will include functional capacity, assessed using “Six minutes walking 
test”, muscular strength, measured with handgrip, and leg press strength.  Patients’ 
quality of life (QoL) will be assessed using the European Organization for Research 







Cancer is a significant public health problem worldwide, as well as in Italy, being 
the second leading cause of mortality (109). The costs associated with cancer care 
are growing due to the new expensive therapeutic strategies and the combination of 
increases in cancer cases and survival rates, which has enhanced the prevalence; 
indeed, it is estimated that it will be about 3.6 million Italian people with a cancer 
diagnosis in 2020 (110).  
Cancer and its specific anti-tumor treatments, like chemotherapy, radiation, 
hormonotherapy, but also the new therapeutic options (e.g., target therapy or 
immunotherapy), can profoundly harm the patient's integrity, with significant 
consequences on the physical and psychological point of views (7). 
Cancer patients experience multidimensional side effects, like fatigue, nausea, pain, 
anxiety and psychological distress, and an accelerated functional decline (7). These 
patients are at higher risk of developing serious comorbid conditions, such as 
metabolic disorders, cardiovascular diseases, sarcopenia, and osteoporosis, 
compared to the general population (111). Collectively, these sequelae can lead to 
an impairment in quality of life during patient disease trajectory (111). 
Physical exercise is emerging as an important adjunct therapy in the cancer context. 
Epidemiological studies show that post-diagnosis physical activity is associated 
with increased cancer patients' survival, especially breast, colon, and prostate 
cancers (5). Exercise is an effective strategy to relieve some symptoms and 
impairments occurring in cancer patients (111). Specifically, studies report a range 
of benefits deriving from an active lifestyle, as control fatigue, anxiety, and 
depression levels, alleviate psychological distress and counteract functional decline 
by improving health-related skills and quality of life (111).  
Although physical exercise is routinely recommended by several important 
organizations like the American Cancer Society (112), American College of Sports 
Medicine (7), Clinical Oncology Society of Australia (15), most patients do not 
reach the appropriate levels of exercise (86).  
Exercise is a complex behavior that to have successful results in terms of 
maintenance over time, and outcomes should take into account motivation, 
preferences, and barriers experienced by the patients (10). 
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In this sense, we have developed the CHOiCE (Choose Health, Oncological patients 
Centered Exercise) trial. The CHOiCE study consists of an exercise intervention 
aiming to alleviate cancer- and treatment-related side effects and improve patients' 
physical and psychological outcomes (Figure 1.). To create a patient-centered 
program, we have been performed two implementation studies exploring patients' 
exercise preferences (86), on one hand, barriers and facilitators of adopting an 
active lifestyle (113), on the other. These investigations revealed that cancer 
patients have a series of favorite issues regarding exercise counseling, 
programming, and organization as well as specific barriers (e.g., treatments side 
effects, medications) and facilitators (e.g., setting goals, exercise program targeted 
on patient' disease and comorbidities, available exercise specialist), that can 
potentially hinder or trigger patients exercise. Tailor an exercise program, 
considering preferences, barriers, and cues to action of cancer patients may 
positively affect exercise adherence maintenance. Simultaneously, to propose an 
evidence-based program in terms of health-related outcomes, the CHOiCE 
intervention is implemented according to the current American College of Sports 
Medicine exercise guidelines for cancer patients (7). These guidelines suggest that 
an exercise prescription should last 8-12 weeks and include moderate-intensity 
aerobic exercise at least three times per week, 30 minutes each session, and strength 
activity, two times, per week, with two sets of 8-15 repetitions at least 60% of one-
repetition maximum. Herein, we present the study protocol of the CHOiCE trial, 
aiming to test its safety and feasibility and explore its preliminary efficacy on 




The CHOiCE trial is a two-sites, prospective, two-armed, phase II randomized 
controlled trial, promoted by the University of Verona, Department of 
Neuroscience, Biomedicine e Movement Sciences, Verona, Italy, and by the Italian 
cancer patients' organization "LILT (Italian League for Fight Against Cancer), 
Biella, Italy. The study was approved by the Ethics Committee for Clinical Trials 
for the University of Verona (Prot. No. 33320), and the Ethics Committee of Novara 
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for LILT (Prot. No. CE 158/19), Novara, and is registered on ClinicalTrials.gov 
(ID: NCT04226508). All the procedures, based on the SPIRIT guidelines (114), are 




Figure 2. Flow diagram of the CHOiCE trial 
 
Study population 
Eligibility criteria are: (i) age ≥18 years, (ii) medical clearance to participate in the 




Assessed for eligibility 
Excluded 
● Not meeting the eligibility 
criteria 
● Declined to participate 
● Other reason 
Baseline assessment 
Randomized (n=80) 
Exercise group (n=40) Control group (n=40) 
12-week postintervention assessments 
3-month follow-up assessments 
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cancer sites: female breast, colorectum, lung, prostate, ovary, uterus, or cervix. 
Exclusion criteria include: (i) recurrence or metastatic disease, (ii) pregnancy, (iii) 
Karnofsky index (performance status) <50, (iv) a compromised mental status, (v) < 
8 weeks from latest surgery, and (vi) a planned surgery during the intervention. 
Recruitment 
Patients are recruited through the facilities of Oncology Units of Verona and Biella, 
Italy. Eligible patients are identified through medical records, and during the 
checkup visits, a physician introduces the study. If interested, the patients are 
contacted by the research team to receive a detailed explanation about the study's 
procedures and conduction. Those patients who agree to participate are asked to 
sign the written informed consent. 
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Table 1. Study activity/assessment plan for the CHOiCE trial based on the Standard Protocol Items: Recommendation for Interventional 
Trials 
Activity/ 






































5min  X     
Interventions         
Exercise training  Kinesiologist 
~ 1 hour 
per session 
  ● ●   
Usual care  N/A    ● ●   






10 min  X     
Feasibility of the 
intervention 




Kinesiologist 25 min  X   X X 
Patient-reported 
outcomes 




Randomization and blinding 
All study participants are randomly assigned to the intervention or control arm. For 
the two sites (Verona and Biella), block randomization of four is performed to 
facilitate an equal distribution matching per center between the two study groups. 
The computer generation of numbers is produced by the coordinating center and 
concealed from study staff involved in the recruitment and baseline assessment. 
Due to the nature of the exercise intervention, it is not possible to blind participants 
or interventionists to group allocations. Assignments to controls or intervention are 
made in the order in which participants complete the baseline assessment. 
 
Interventions 
Exercise intervention arm 
Patients randomized to the intervention group are asked to complete a 12-week 
supervised training. The participants can choose between the following three 
exercise modality: 
− Autonomous supervised program, which consists of a personalized written 
exercise program to perform at home. In this program, all the activities to 
perform, the frequency, the duration, and the intensity are specifically 
described. Periodical meetings, at 2, 4, and 6 weeks, are scheduled to hand 
the new program and try the exercises with a kinesiologist. A detailed 
training diary is proposed for monitoring the intervention. 
− Personal training program, which consists of an intervention with a 
kinesiologist-patient ratio of 1:1. The intervention takes place in the gym. 
− Group training program, which consists of an intervention to perform in 
small groups at the facilities of the two centers. The kinesiologist-patients 
ratio is 1:4-1:8, basing on the functional conditions of the participants. 
 
The training progression and prescription of aerobic and strength exercises are the 
same for all three modalities, depending on the patient's baseline conditions (Table 
2.), and are planned according to the current exercise guidelines for cancer patients.  
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Exercise sessions consist of bi-weekly training, including warm-up, aerobic and 
resistance training, and cool-down (Table 2.). Warm-up lasts 5-10 minutes, and it 
is composed of 10 dynamic stretching exercises to prepare the body for exercise 
and reduce the risk of injury. The aerobic component comprises cardiovascular 
exercises, such as walking, jogging, cycling, lasting from 10 to 30 minutes at 
moderate intensity, i.e., 3-5 of the 10-point Borg Rating of the Perceived Exertion 
Scale. The amount of aerobic activity starts according to the patients' baseline 
conditions, progressively increases over the weeks until it reaches 30 minutes each 
session at moderate intensity. Resistance training components include six body 
weight or elastic bands exercises involving the major upper and lower body muscle 
groups. The selection of exercises is individually prescribed, and each of these is 
performed in 2-3 sets of 8-12 repetitions, at moderate intensity, i.e., 3-5 of the 10-
point Borg Rating of the Perceived Exertion Scale. Resistance training prescription 
progressively increases, basing patient response. Cool-down is composed of 5 
stretching exercises of the major muscle groups for 30 seconds duration each. 
Additionally, all patients are encouraged to perform a walking activity 
autonomously. Steps goals are proposed, through a personalized pamphlet, to be 
achieved at least one day in a week, with a gradual increase over the week, with the 
aim to reach at least 10,000 steps, approximately corresponding to 30 minutes. A 
walking diary is proposed for monitoring the number of steps achieved. 
Each patient is provided with a Borg Scale copy, a pedometer (OnWalk 500, 




Table 2. CHOiCE intervention exercise prescription 
Intervention 
week 






















of 0 to 10) 
Frequency 
per week 
Number of steps 
1 2 15 (10 to 20) 3-5 2 2x8 3-5 1 6000 (5000 to 7000) 
2 2 15 (10 to 20) 3-5 2 2x8 3-5 1 6500 (5500 to 7500) 
3 2 20 (15 to 25) 3-5 2 2x10 3-5 1 7000 (6000 to 8000) 
4 2 20 (15 to 25) 3-5 2 2x10 3-5 1 7500 (6500 to 8500) 
5 2 25 (20 to 30) 3-5 2 2x12 3-5 1 8000 (7000 to 9000) 
6 2 25 (20 to 30) 3-5 2 2x12 3-5 1 8500 (7500 to 9500) 
7 2 30 (25 to >30) 3-5 2 3x8 3-5 1 9000 (8000 to 10000) 
8 2 30 (25 to >30) 3-5 2 3x8 3-5 1 9500 (8500 to >10000) 
9 2 30 (30 to >30) 3-5 2 3x10 3-5 1 10000 (9000 to >10000) 
10 2 30 (30 to >30) 3-5 2 3x10 3-5 1 >10000 (9500 to >10000) 
11 2 30 (30 to >30) 3-5 2 3x12 3-5 1 >10000 (10000 to >10000) 





Patients randomized in the control arm are instructed to manage their lifestyle in a 
completely autonomous way. They are informed face to face about the benefits of 
exercise and the guidelines for cancer patients, but no instructions or advice are 
delivered to improve their exercise. At the end of the intervention study, patients 
allocated in the control arm will be offered to participate in one of the three 
programs proposed to the intervention group. 
 
Outcome measurements 




Safety and feasibility. Safety and feasibility are recorded continuously during the 
study. Regarding safety, we record the adverse events, defined as any undesirable 
medical or health-related event that occurred during study participation. They are 
classified as either non-exercise adverse events (adverse events reported to have 
occurred during study participation but considered unrelated to exercise) or 
exercise-related adverse events (events that occurred during or as a direct result of 
exercise). Adverse events are categorized according to the Common Terminology 
Criteria for Adverse Events (version 5.0) (115). Feasibility variables include: 
recruitment rate, adherence, and withdrawals. The recruitment rate will be 
evaluated by dividing the number of randomized patients by the patients considered 
eligible. Adherence at assessments will be determined by the total attendance at the 
evaluation moments. Adherence at the training sessions will be calculated by the 
total attendance at the training sessions. The withdrawal rate will be registered, 
including the number of patients that leave the study.   
 
Secondary outcomes 
Functional capacity. Functional capacity is measured through the "Six minutes 
walking test," conducted according to the American Thoracic Society guidelines 
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(116). This assessment is largely utilized and proven to be safe in subjects with 
cancer (117). Following a standardized protocol, the patients are instructed to walk 
at their own pace in a 20-m hallway. The goal is to cover as much distance as 
possible in 6 minutes. Pulse rate and oxygen saturation are monitored before, 
during, and after testing. The patient's perceived exertion is recorded after testing 
using Borg Scale. 
Strength. Muscular strength is evaluated through maximal voluntary isometric 
contraction of upper and lower limbs. Handgrip strength test, using a hydraulic hand 
dynamometer (Model SH5001, Saehan Corporation, South Korea), is proposed to 
evaluate the grip strength. The subject is sitting in a straight‐backed chair with the 
feet flat on the floor, the shoulder adducted and neutrally rotated, elbow flexed at 
90 degrees, forearm in a neutral position, and the wrist between 0-30 degrees 
extension and between 0-15 degrees ulnar deviation (118). An isometric leg press 
test is proposed for lower limb strength, using a load cell (564QDT, S2Tech Srl, 
Italy) mounted a horizontal leg press. The load cell is positioned in series with the 
leg press's sliding axis to register the direct line of force. The dynamometer is 
routinely calibrated using ISO-certified weights. The leg-press back, on which the 
subjects were lying, was inclined 30° from the horizontal plane. The knee angle is 
set at about 100° and was controlled using a goniometer (119). For both strength 
assessments, five tests are performed; each voluntary contraction will be kept for 
2-4 seconds. The patient's perceived exertion is recorded after testing using Borg 
Scale. 
Flexibility. The sit and reach test measures the lower body flexibility. The 
participant sits on the floor and extends the legs straight out in front of the hip with 
foot flexed and heel resting on the floor. The object is to reach forward as possible 
or past to toes. For upper limbs, we use the back-scratch test. This test, which 
involves a combination of shoulder abduction, adduction, internal and external 
rotation, involves measuring the distance between (or the overlap of) the middle 
fingers behind the back (120). For both evaluations, two tests are performed.  
Anthropometric measures. Anthropometric parameters include body weight and 
height and the hip and waist circumferences of the subjects. Anthropometric 
measurements are taken by trained personnel using standard protocols (121). 
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Weight and height are measured with subjects wearing no shoes to the nearest 0.1 
kilograms and to the nearest 1.0 centimeter). Waist circumference (cm) is measured 
at the narrowest circumference of the torso, while hip circumference (cm) is 
measured horizontally at the level of the largest lateral extension of the hips. 
These data allow the calculation of the body mass index (BMI) - obtained by the 
weight (in kilograms) of the subjects divided by the square of their height (in 
meters) - and of the waist-hip ratio - obtained by the ratio of waist and hip 
circumferences (in centimeters) (121).  
Quality of life. Health-related quality of life is measured using the European 
Organization for Research and Treatment of Cancer Quality of Life and Core 
Questionnaire (EORTC QLQ C-30), Italian version, a 30-item questionnaire 
composed of multi-item scales and single items that reflect the multidimensionality 
of the quality-of-life construct. It incorporates five functional scales (physical, role, 
cognitive, emotional, and social), three symptom scales (fatigue, pain, and nausea 
and vomiting), and a global health and quality-of-life scale. The remaining single 
items assess additional symptoms commonly reported by cancer patients (dyspnea, 
appetite loss, sleep disturbance, constipation, and diarrhea). For all scales, item 
scores are summed and linearly transformed into a scale ranging from0 to 100. 
Higher scores on the functioning scales indicate higher levels of functioning, 
whereas higher scores on the symptom scales represent more symptom burden 
(122). 
Exercise level. Exercise level is evaluated using the adapted version Godin's 
Shepard Leisure Time Exercise Questionnaire. The questionnaire enquires about 
the previous week's leisure time-frequency (times/week) and duration (min/time) 
of vigorous, moderate-and mild-intensity exercise. Patients are classified as active 
or insufficiently active based on the leisure score index, using the metabolic 
equivalent of the task (METs) (58). 
Exercise enjoyment. Enjoyment is assessed using the Italian version Physical 
Activity Enjoyment Scale. The PAES is a 16 items questionnaire to evaluate the 
person's enjoyment of the physical activity. Enjoyment has shown to be a handy 
parameter in exercise interventions, both to determining adherence in a program 
and to be one of the mediators for a lifestyle behavior change (123). 
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Socio-demographic and medical variables. Socio-demographic information will be 
collected at baseline with a self-compiled questionnaire investigating: age, gender 
(male/ female), education (elementary/ secondary/ high school degree/ 
undergraduate degree/ postgraduate degree), marital status (unmarried/ married/ 
divorced/ widow), and employment (retired/ in search of employment/ stay-at-
home or housewife/ part-time employed/ full time employed). Clinical data will be 
extracted by medical charts at baseline, including: location of the tumor (organ), 
stage of the disease, tumor treatment, date of the diagnosis, comorbidity, and drug 
treatments. 
 
Data Collection and management 
The data entry will be executed in parallel with their completion. A sample of 
questionnaires and functional assessments (10%) will be entered in duplicate by 
independent operators and compared. If there more than 5% discrepancies, the 
whole data entry will be duplicated to assure control quality. Computer access and 
data directory will be protected by username and password, periodically changed. 
Access to the data entry program for the questionnaires is protected by username 




A purposely developed mandatory course, lasting 20 hours, is proposed to the 
kinesiologist, who conducts the exercise program. The course will cover the 
following topics: 1) overview of scientific literature concerning exercise in cancer 
patients; 2) presentation of the CHOiCE study and its protocol; 3) assessment, 
schedule, and conduct exercise and procedures adopted in the study; 4) emergency 







This study is designed to evaluate the feasibility and to obtain preliminary data for 
power calculations for a future large randomized controlled trial. Consequently, a 
priori sample size calculation is not performed. Considering the access rates to the 
facilities involved in the study, we estimate to include 80 patients. 
 
Analysis 
For the primary outcome, absolute frequencies and percentages will be utilized to 
present the recruitment rate, the adherence to assessments and training sessions, 
drop-up rate, and adverse events. Descriptive analyses will be generated for 
demographics, clinic data, and baseline evaluations. Student t-test, for continuous 
variables and Fisher's exact test, for categorical parameters will be proposed to 
detect baseline group differences. An intention-to-treat principle will be chosen to 
include all the study participants in the analysis. To compare the effect of the 
exercise intervention versus the control, the Student t-test or the equivalent non-
parametric U Mann-Whitney test will be proposed if the comparison takes place in 
a single timepoint. To detect differences at different timepoints, repeated-measure 
analysis of ANOVA model or the equivalent non-parametric Friedman test, 
adjusting for baseline characteristics, will be applied. If missing data will be ≥10%, 
a multiple imputation missing data strategy will be employed. All statistical 
analyses will be conducted using STATA 14, and interpretation data will be based 
on the p-value of two-tailed <0.05. 
 
Limitations, strengths, conclusion, and future perspectives 
The CHOiCE study has important weaknesses that should be noted. The study 
population is comprised of some cancer type, excluding patients with metastatic or 
recurrent disease. Thus, the study population may not be representative of all people 
with cancer, making the results a little generalizable. Evaluation of the CHOiCE 
program is addressed to explore its feasibility and impact on patient’s health-related 
skills and quality of life, while the impact on cost and cost-effectiveness of the 
interventions have not been investigated. However, these limitations are offset by 
strengths to the implementation of the CHOiCE program. This is one of the first 
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programs in Italy, specifically tailored to patients’ preferences, perceived barriers, 
and needs, and developed from two previous implementation studies. Moreover, 
this is a feasibility trial to investigate if the program can be done; thus, the current 
limitations may be fill in a future large trial.  
There is a dearth of knowledge about an effective approach to translating exercise 
oncology evidence into real context, especially in a country like Italy still orphan 
in exercise oncology. To bridge this gap, the CHOiCE program is specifically 
designed for cancer patients with the aim to provide the patients an evidence-based 
exercise approach. If, after this feasibility study, a large randomized controlled trial 
will demonstrate the efficacy and the sustainability of the CHOiCE, it may be 
expanded across the country with the aim to reduce the disease burden of cancer 
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Whereas the coronavirus disease (COVID-19) storm is relentlessly progressing 
worldwide, a great effort from scientific societies has been made in order to give 
recommendations for safely continuing oncological care, prioritizing the 
interventions according to patient’s condition, type and stage of tumor. 
Nevertheless, to date no specific suggestions regarding physical activity and 
exercise in cancer patients during the COVID-19 era have been released, neglecting 
the potential deleterious effects of quarantine and sedentary (imposed as 
containment measures against COVID-19), particularly in these subjects. 
Moreover, literature is constantly consolidating the crucial impact of regular 
physical activity in cancer in reducing recurrence and mortality risk. In this 
Commentary, we discuss possible adaptations of the recently published exercise 
guidelines to the current pandemic emergency, proposing various modalities to 





Since the new coronavirus (COVID-19), also known as SARS-CoV-2 (severe acute 
respiratory syndrome coronavirus 2) was announced in Wuhan in late December 
2019, it has rapidly spread worldwide, prompting the World Health Organization 
(WHO) to declare the pandemic on March 11, 2020 (124). Due to the high 
contagiousness and aggressiveness of this disease, on July 28, more than 
16,341,920 cases and 650,805 related deaths have been reported around the world 
(124).  COVID-19 patients can be completely asymptomatic (around 18% of cases) 
(125) or manifest several symptoms, ranging from mild to severe, mainly including 
respiratory manifestations (e.g., rhinorrhea, sneezing, sore throat, cough, ground-
glass opacities, pneumonia, hypoxemia, dyspnea, acute respiratory syndrome), but 
also systemic disorders (e.g., fever, fatigue, headache, coagulation disorders, 
lymphopenia, and other blood alterations, gastrointestinal symptoms as diarrhea 
and nausea) (126).  
Preliminary data suggest that elderly subjects (127) and/or with pre-existing chronic 
comorbidities (128) may be at higher risk of COVID-19 incidence occurring with 
a worse outcome (127, 128). In particular, cancer patients seem to represent a high-
risk category to experience COVID-19 disease with more severe manifestations, 
mainly due to compromised immune defenses and sequelae of antineoplastic 
treatments (128). Thus, given the current pandemic emergency, a great effort from 
scientific societies was performed in order to provide recommendations for safely 
continuing oncological care, prioritizing the interventions according to patient’s 
condition, type and stage of tumor (129). Nevertheless, the emergency may 
unequivocally lead to postponing some anticancer treatments (128, 129), further 
increasing patients’ anxiety and distress levels and therefore lowering compliance 
to therapy. 
Because up to now, no vaccine or specific treatments against COVID-19 are 
available, the only way to keep the spread of the infection under control is the social 
distancing, i.e., keeping people at home as much as possible, for as long as possible, 
until pandemic will recede. Indeed, several countries around the world have adopted 
various containment measures (130). In Italy, for example, the national quarantine, 
i.e., the prohibition for all people to move except for work, necessity, or medical 
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needs, began on March 9, 2020, and it lasted until May 18, 2020, when a gradual 
reopening of commercial, productive and social activities was allowed (131). 
Although these measures are strictly necessary, social distancing and quarantine 
may also have negative effects. A recent review has explored the impact of 
quarantine on psychological status, describing a high risk of post-traumatic stress 
symptoms, confusion, and anger (132). Moreover, this homestay period may likely 
lead to reduce physical activity (PA) and thus increase sedentary behaviors. In 
general population, PA and sedentary time are respectively associated with positive 
and negative effects on body systems, mainly on muscle mass and cardiorespiratory 
fitness. Recent evidence highlighted the correlation between lack of PA/sedentary 
and risk of several chronic conditions as metabolic syndrome, osteoporosis, 
cardiovascular and respiratory disease, stroke, cognitive function, and type 2 
diabetes (133, 134). 
 
Physical activity and exercise in cancer 
Despite WHO underlined the importance to be as active as possible during this 
quarantine period, it is reasonable to speculate that one of the groups significantly 
decreasing its PA level is the oncological population. In this regard, patients usually 
reported a reduction in PA level after cancer diagnosis (42), with only 
approximately one-third of patients satisfying PA recommendations (17). In our 
experience, such proportion seems to be even smaller (135). Due to the current 
restrictions, this number could further diminish, amplifying the deleterious effects 
of sedentary behavior and physical inactivity.  
PA is emerging as a key element in the oncological trajectory. A growing body of 
literature demonstrated the association between PA levels after a cancer diagnosis 
and survival (5). Collectively, these data reported a consistent, inverse correlation 
with all-cause mortality (ranging from 21% to 45%) and cancer-specific mortality 
(ranging from 26% to 69%) risk (5). Furthermore, some physical fitness 
components harbor a relevant impact in terms of both prognosis and recurrence risk. 
Cardiorespiratory fitness and muscular strength are prognostic factors in cancer 
patients(10). In addition, muscle mass wasting has been connected with a worse 
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treatment tolerance, higher risk of recurrence, overall, and cancer-specific mortality 
(136, 137).  
PA and exercise (EX) interventions are shown to be safe and feasible in oncological 
patients (7). A recent meta-analysis, including 48 randomized controlled trials with 
a total of 3,632 patients, found that EX increases the peak of oxygen consumption 
by +2.80 mLO2*kg
-1*min-1 in the interventional group compared with no changes 
in the control one (8). Padilha and colleagues have investigated the role of 
resistance training or a combined EX program (aerobic + resistance) on muscle 
mass, strength, and body fat. The results have demonstrated that EX was effective 
in improving muscular strength, regardless of the type of anticancer treatment, 
concomitantly increasing lean body mass and decreasing body fat (9). Over the 
years, the role of PA and EX as a strategy to improve health-related quality of life 
in cancer patients has been established (7, 17). This could be partially associated 
with the efficacy of EX in alleviating or preventing cancer- and treatment-related 
adverse events, such as cancer-related fatigue, lymphedema, anxiety and depression 
levels, bone health, sleep quality, as well as cardiotoxicity risk, cognitive function, 
sexual function, chemotherapy-induced peripheral neuropathy, and nausea (7). 
Finally, limited data also exist concerning treatment tolerance, i.e., the completion 
of or the adherence to planned therapy. In fact, EX may improve the chemotherapy 
completion rate in patients physically active during adjuvant treatments comparing 
to the control group (7). 
 
Efficacy of home EX programs in oncology 
The American College of Sports Medicine (ACSM) has released the new EX 
guidelines for cancer survivors (7). ACSM suggests that an effective EX 
prescription should include moderate-intensity aerobic training at least three times 
per week for 8-12 weeks. Moreover, the EX program should add resistance training 
activities, at least two times per week, using two sets of 8-15 repetitions at least 
60% of one maximum repetition (7). 
According to the current pandemic emergency, these guidelines should be adapted 
to a home-based setting since supervised sessions are not possible. A reliable 
solution can be represented by home-based EX programs. The home-based EX 
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programs can exploit the telehealth (or telemedicine), i.e., the remote delivery of 
health care as well as a range of other services, including patient education and 
wellness promotion through technology (138). Telehealth programs do not have a 
formal structure to deliver information and can utilize different technologies, 
therefore allowing the EX prescription and monitoring in several ways (138). For 
example, in cancer survivors telephone counseling, short message services, digital 
media (e.g., DVD), tailored and/or mailed materials, and/or computer/web-assisted 
programs, were applied (139). Moreover, the home-based EX programs are 
feasible, usually well accepted, and can be facilitated through the social support 
deriving from the patient’s family and the possibility to self-organize the free time, 
choosing when to perform the activities (140). If well structured, including, for 
example, an initial phase to educate patients (e.g., to self-monitor the intensity), 
home-based programs have been demonstrated to be efficacious in improving 
lifestyle in cancer population. In this regard, Demark-Wahnefried and colleagues 
have proposed a randomized trial, including 519 newly diagnosed breast and 
prostate cancer survivors, with the aim to improve diet and EX practice using a 
tailored mail print intervention (141). The intervention included personalized 
workbooks followed by a series of newsletters (at 6-week intervals) that were 
tailored to barriers, stage of readiness, and progress towards goal attainment of 
exercising and nutritional aspects (141). Patients also received a survey on the 
current health practices and the willingness of starting and maintaining a lifestyle 
change, which was used to adapt the periodic newsletters (141). The study increased 
the weekly time spent in EX, improved the overall diet quality, the daily intake of 
fruits and vegetables, decreasing fat intake and weight (141). In the recent years, 
thanks to the advent of technology in the PA context, a growing number of studies 
have tested different internet approaches for PA/EX programs, as web-based system 
(142), mobile application (143) or social media (e.g., Facebook) interventions 
(144), finding positive and meaningful results. Along these lines, a recent 
randomized trial tested a web-based EX program in 68 breast cancer patients 
undergoing chemotherapy, to determine the effectiveness in preventing the 
impairment of functional capacity, muscular strength and anthropometric 
parameters, usually experimented during chemotherapy periods. The intervention 
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consisted in an 8-week, web-based EX program, with three sessions per week, 
which were organized in warm-up, aerobic and strength activities. The web system 
also permitted the communication between patients and research staff and weekly 
contacts with the aim to assure the correct performance and to tailor the program 
according to patients’ needs (142). The results demonstrated the intervention 
effectiveness in terms of both cardiorespiratory fitness and muscular strength, 
ameliorating the detrimental effects of treatments (142).  
Nevertheless, the application of telehealth should be also considered outside the 
pandemic emergency. Due to the constant improvement in prevention, diagnosis 
and treatments, the number of cancer patients and survivors is fortunately 
continuously increasing, and the financial resources available for supporting EX 
program could be limited. The home-based EX program can offer a low-cost and 
sustainable alternative, especially when the costs are borne by the patients (145). In 
this regard, van Waart and colleagues, in a sample of 230 breast and colon cancer 
patients, evaluated the cost-utility and cost-effectiveness of two different PA 
programs compared to usual care. The home-based low-intensity PA program cost 
€46 (~$53) per participant, whereas the moderate-high intensity, supervised EX 
program, cost €757 (~$849) (146). Although the high willingness-to-pay may limit 
the cost-effectiveness of the home-based low-intensity PA program (146), no 
definitive data are available in this sense. 
Apart from the limited cost, telehealth offers the opportunity of easily spreading the 
access to EX programs for cancer patients. For example, patients living in rural or 
remote communities are at high risk of being under-served in terms of healthcare 
and health-related services. Indeed, a recent study has reported that rural cancer 
survivors are 2.6 times less likely to meet aerobic PA guidelines than urban cancer 
survivors (147). This population should face the burden and discomfort of travel 
time to reach the services, thus decreasing the willingness to start a supervised EX 
program. This statement is also confirmed by interesting research, evaluating the 
EX preferences in rural breast cancer survivors. Seventy-six percent of patients 
were interested in participating in an EX program, the majority preferred to perform 
EX at home (63%), and almost half (47%) of the participants favored an 
unsupervised program, endorsing the hypothesis that a remote EX program could 
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be well accepted by a rural cancer population (54). Telehealth can allow 
overcoming these barriers and indirectly diminish the disparity in survival and 
disease-related outcomes existing between non-metropolitan and metropolitan 
patients (148). 
 
Practical considerations to increase EX level in cancer patients during 
COVID-19 pandemic 
According to the aforementioned evidence and with the current containment 
measures, several modalities are available to support an effective home-based EX 





Figure 1. Proposed model of a home-based exercise intervention dedicated to 
cancer patients. 
 
The COVID-19 outbreak makes necessary to remotely perform all the steps of EX 
prescription, which are usually carried out face-to-face. The health-related physical 
fitness can be hard to test in this framework. Nevertheless, an initial evaluation may 
be proposed at distance through a videoconference for example, especially for those 
patients starting an EX program (Figure 1). Ideally, this phase should include 
different assessments. From one side, patients’ health history (including cancer 
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type/stage and comorbidities), current treatments, presence and severity of side 
effects, and screening tools to assess the EX risk are essential to prescribe a safe 
program (7, 149). On the other hand, understanding EX preferences, barriers, 
facilitators, availability of resources to support EX engagement, and patients’ EX 
history can be useful to build a tailored and feasible program (7, 149). Several and 
validate tools are available for the exercise physiologist or kinesiologist to achieve 
this phase. For example, the Physical Activity Readiness Questionnaire can help 
defining an initial risk profile of the subject (150), whereas the European 
Organization for research and Treatment of Cancer QLQ-C30 can measure the 
quality of life and the severity of some symptoms and treatment-related side effects 
(122).  
Paradoxically, the social distancing period may be a good time to start an EX 
program, because some barriers that usually interfere with an active lifestyle 
adoption, e.g., distance from gym, lack of time, traffic and fixed time for lessons 
are missing. Setting goals and track progresses (Figure1.) using different 
instruments (e.g., wearable technology and/or a personalized diary) can be an ideal 
strategy to stimulate patients to maintain adherence to the prescribed EX program 
(149). 
Goals should be established with the subjects, according to the following 
characteristics: specificity, measurability, achievability, realistic goals, and time-
availability. Cancer patients have unique needs related to their disease, therefore 
choosing the most appropriate goals should take all of them into consideration (e.g. 
symptom control, improving mood and/or bodyweight, increasing EX level), 
selecting those that are remotely assessable and most important for the subject. 
Moreover, the kinesiologist or physiotherapist should help the patients to recognize 
the EX-related goals that are realistic and achievable by themselves. This aspect is 
particularly crucial because failure in achieving the proposed goals can be 
extremely demotivating, particularly for oncological patients, with the possible 
consequence of EX program drop out. Finally, goals should be time-based, 
remembering that the EX prescription objectives may be influenced by the change 
in disease and treatment-related toxicities over time. 
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Another component that should be included into a home-based program, especially 
during the COVID-19 pandemic period, is the periodic follow-up (Figure1.) (149). 
This is important to maintain high engagement (151) and can be delivered by 
several modalities, e.g. telephone, video-chat platforms (i.e. Skype), or email. The 
aims of the follow-up can be various: educate subjects to manage the EX training, 
supervise the program, support patients to maintain an active lifestyle stimulating 
their motivation, reassess the situation, and modify the prescription. Follow-up time 
depends on several factors, e.g., the modality to deliver the program and the 
patients’ needs. These revaluations could be in a short-interval at the beginning of 
the program to maximize patient’s support and longer later to favor the subject’ 
autonomy.  
The EX-program components should reflect guidelines, including type, frequency, 
duration, and intensity of the activities (7). Aerobic and strength exercises should 
be a key component of the EX prescription, and their balancing should be 
determined according to the patient’s goals and needs. Whereas strength activities 
require small spaces and limited equipment (e.g., elastic bands, body-weight 
exercises), the aerobic exercises could be hard to be included into a home-based 
program. If it is not possible to get outside or if the patient does not hold a specific 
machine (e.g., treadmill or cycle ergometer), a valid alternative could be 
represented by adapted exercises as dancing, or walk up and down the stairs, for 
example. Moreover, the program should also include flexibility and proprioceptive 
training, especially for patients with specific symptoms or treatment-related side 
effects. Proprioceptive exercises could improve chemotherapy-induced neuropathy, 
reducing this tiresome symptom and ameliorating the balance control, whereas 
regain the joint range of motion through flexibility activities, could be beneficial 
for patients undergone surgery and presenting a limited range of joint extension. 
In the home-based program, patients must be educated to self-monitoring EX-
intensity because, even if low-intensity may be appropriated for deconditioned 
patients, in other cases it may be insufficient to significantly perturb the body 
homeostasis and increase the functionality, while high intensity may be unsafe. 
Thus, it is important to educate the patients to understand the intensity level using 
some practical tools, such as the heart rate or the perceived exertion scale.  
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Frequency, i.e., the number of sessions per week, and duration, the time or the 
sets/repetitions per session/activity, are also essential to be defined. Although the 
ACSM guidelines suggest a frequency of 2-3 times per week of 90 minutes of 
aerobic activities and two sets of 8-15 repetitions for strength training, it may be 
necessary to adapt these parameters to the peculiar patient’s clinical situation and 
disease. During the quarantine, patients have more free time to spend in exercising, 
but they may be sedentary or deconditioned, thus increase the frequency and 
diminish the duration may be a strategy to adopt. Nevertheless, it is necessary to 
remember that the “dosage” of EX, in terms of type, frequency, duration and 
intensity, recommended by ACSM, may be not appropriate at the beginning for 
cancer patients and should be progressively reached, balancing the EX-prescription 
components with the patient capacity. 
Considering all these factors may allow to develop effective tailored EX programs 
during COVID-19, which can be potentially carried on beyond quarantine period, 
in order to reduce the negative effect of sedentary, increase benefits related to PA 




The COVID-19 outbreak is threat global public health. Until a vaccine and specific 
therapies against COVID-19 are available, physical distancing and homestay 
remain effective approaches to slow down the spread of the disease; however, such 
restrictive measures may decrease PA levels in cancer patients, with consequent 
deleterious outcomes in the long term. In this light, promoting a remote home-based 
lifestyle intervention in cancer population is an urgency, because if social 
distancing is necessary to stay healthy “today”, the physical inactivity that may be 
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Introduction: Cachexia represents a relevant issue in oncological care, still lacking 
of validate therapies. Although the incidence of cancer cachexia varies across 
cancer types, it is responsible for approximately a quarter of cancer-related deaths. 
The pathophysiology of this syndrome is multifactorial, including weight loss, 
muscle atrophy and impairment of the pro-/anti-inflammatory balance.  
Areas covered: Diagnostic criteria and optimal endpoints for cachexia-dedicated 
trials are still debated, slowing the identification of interventions counteracting 
cachexia sequaele. The multi-faced features of this syndrome support the rationale 
for a personalized therapy. Multimodal approach is likely to offer the best option to 
address the key cachexia-related issues. Pharmacologic agents, physical exercise, 
nutritional and psycho-social interventions may have a synergistic effect, able to 
improve the quality of life.  
Expert opinion: A personalized multimodal intervention could represent the best 
strategy to effectively manage cancer cachexia. To offer such a comprehensive 
approach, a specialized staff, including health professionals with different 
expertise, is necessary. Each specialist plays a specific role inside the multimodal 
intervention, with the aim to deliver the best cancer care and access to the most 





Cachexia, from the Greek terms kakos, i.e. "bad", and hexis, i.e. "conditions", 
remains one of the most devastating cancer-related adverse events, typically (but 
not exclusively) occurring at an advanced disease stage. An international consensus 
statement defined cachexia as: "a multifactorial syndrome characterised by 
ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot 
be fully reversed by conventional nutritional support and leads to progressive 
functional impairment" (152). Cachexia is prevalent in patients affected by liver 
(50.1%) pancreatic (45.6%) head and neck (42.3%), thyroid (39.9%), and lung 
(37.2%) cancers (153). It is an important mortality cause, accounting for almost 
20% of cancer patients' deaths (154). Moreover, this condition can interfere with 
cancer trajectory, reducing treatment tolerance and increasing the length of hospital 
stay, as well as the overall treatment expenses (155, 156). To date, cachexia 
represents a major challenge in cancer care because of several gaps existing in its 
diagnosis, assessment, and treatment. 
 
Symptoms and mechanisms of cachexia 
Weight loss is considered one of the major features of cancer cachexia (157). 
Indeed, cancer patients often present an energy imbalance due to an increased 
energy expenditure in comparison with the caloric intake (158). In detail, cachectic 
patients show an alteration in body composition, particularly in terms of muscle 
depletion with or without body fat loss. Loss of muscle mass, specifically in the 
fast-twitch muscle fibers, usually accompanied by cardiac muscle wasting (159), is 
one of the critical manifestations of cachexia in cancer patients, and its 
consequences include an increase in surgical complications, in chemotherapy-
related toxicity, as well as in cancer-related mortality (159, 160). Such muscle 
atrophy is the result of an impaired control of anabolic and catabolic processes, 
mainly due to the overexpression of the ATP-dependent ubiquitin-proteasome 
system and the autophagy/lysosomal proteolytic pathways. Other factors, like 
myostatin and activin A, can induce muscle proteolysis, whereas reduced m-TOR-
dependent protein synthesis and insulin-like growth factor-1 (IGF-1) levels may 
impair anabolic pathways (161). The inflammatory status represents another 
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hallmark of cancer cachexia. Pro-inflammatory factors, including interleukin-6 (IL-
6), tumour necrosis factor-alpha (TNF-α), and interleukin-1 (IL-1), have been 
related to cancer-induced cachexia, especially with wasting of both muscle and fat 
tissue (162, 163). Selective depletion of white adipose tissue is also the result of an 
unfavourable ratio between lipogenesis and lipolysis, due, for example, to the 
activation of hormone-sensitive lipases and to the decrease in lipoprotein lipase 
activity (157). Moreover, emerging evidence suggests that the brain might also play 
a role in cachexia progression: orexigenic and anorexigenic pathways are impaired, 
resulting in reduced appetite, early satiation, and altered taste and smell (157). 
Furthermore, hypothalamic mediators, released in response to persistent 
inflammatory stimuli, participate in weight loss and muscle atrophy (158). 
A large variety of burden symptoms have been associated with cancer cachexia, 
like pain, fatigue, disturbed sleep, lack of appetite, dry mouth, numbness, and lack 
of energy (164, 165). Cachectic patients usually experience a progressive 
impairment of functional abilities and worsening in performance status, which 
results in a progressive reduction of physical activity, finally leading to losing 
autonomy and independence (166, 167). In addition, body composition changes can 
profoundly impair psychological status, enhancing distress, anxiety and depression, 
social isolation, altered self-perception, negative emotions, and conflicts with 
family members (154, 164, 168). Thus, cachexia may have emotional and social 
impact on both patients and their caregivers (169). In conclusion, it is realistic to 
speculate that cancer-related cachexia might drive patients into a vicious circle of 
increased treatment toxicities, higher symptoms burden, diminished physical 
performance, inactivity, malnutrition, and poor psychological status, resulting in an 
overall compromised quality of life (QoL).  
 
Cachexia-related issues 
Pitfalls in diagnosis and assessment 
No universally recognized, international diagnostic criteria for cachexia are 
available, thus making complex to identify this syndrome in clinical practice. 
Fearon et al. proposed weight loss and body mass index (BMI) or sarcopenia as 
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instruments to recognize cachexia (Table 1) (152). This diagnostic criterion was 
able to distinguish cachectic and non-cachectic subjects in terms of survival, intake, 
catabolism, and functionality, in a sample of 1,070 patients with advanced cancer 
(170). Moreover, the prognostic significance of the combination between weight 
loss and BMI was also demonstrated by a large international data set including 
8,675 patients, which allowed to develop (171) and test (172) a grading system able 
of differentiating groups with distinct median survival. However, the diagnosis 
based only on anthropometric parameters might not able to comprehensively 
capture and differentiate the cachectic population, given the complexity of this 
syndrome. Other authors suggest that, in addition to weight loss history, variable 
combinations of those key mechanisms driving cachexia, as the estimation of food 
intake, presence of symptoms, evaluation of systemic inflammation, skeletal 
muscle mass, should be included for its diagnosis. For instance, the SCRINO 
working group proposed a simple method to classify patients as cachectic, based on 
weight loss and presence of anorexia, or fatigue, or early satiation (Table 1) (173). 
Following this line, Evans and colleagues defined cachexia as the presence of 
weight loss plus the presence of three symptoms, including low muscle strength, 
fatigue, anorexia, low fat-free mass index, and abnormal biochemistry 
(inflammation, anemia, low albumin) (Table 1) (174). Moreover, a classification to 
categorize the degree of cachexia was proposed to improve treatment selection and 
early recognize patients at high risk of developing cachexia. In particular, pre-
cachexia, cachexia, and refractory cachexia stages were identified according to the 
percentage of weight loss in combination with the level of depletion of energy stores 
and body protein mass (152). To simplify the score, some authors proposed to apply 
only the grades of pre-cachexia and cachexia (175). Nevertheless, the classification 
intent, especially for the pre-cachexia stage [23], has also been questioned because 
of inconsistent results, lack of sufficient diagnostic criteria, as well as the very low 
prevalence (170, 176, 177). This heterogeneity makes difficult to get a definitive 
concordance between the available different tools (178, 179).  
 




Fearon at al.’ criteria 
(152) 
Bozzetti et al.’s criteria 
(173) 
Evans et al.’s criteria 
(174) 
Weight loss >5% over past 
6 months 
or 
BMI <20.0 kg/m2 and any 
degree of weight loss >2% 
or 
Sarcopenia and any degree 
of weight loss >2% 
Weight loss ≥10% 
and 




Weight loss >5% over past 
12 months or less in 
presence of underlying 
disease (or BMI <20.0 
kg/m2) 
and  
Three out of the following: 
decreased muscle strength 
fatigue 
anorexia 
low fat-free mass index 
abnormal biochemistry (C-
reactive protein, albumin, 
anemia) 
Legend: BMI, body mass index 
 
The uncertainty in cancer-related cachexia diagnosis led to other crucial issues, as 
the eligibility criteria for clinical trials, an increase in the attrition rates, and the 
difficulty in identifying appropriate outcomes, in particular the optimal endpoints 
for cachexia-dedicated trials. Although a call to enhance the regulatory guidance 
for cancer cachexia trials from the European Medicines Agency and the US Food 
and Drug Administration has been advocated (180), up to now, the selection of 
endpoints in the available trials are heterogeneous, often influenced by the 
preferences of researchers and/or pharmaceutical companies (181). Several 
measures have been applied to test the impact of interventions on cancer cachexia. 
Endpoints reflecting clinical benefits, e.g., survival, treatment tolerance, are 
appealing outcomes, given the role of cachexia in cancer-related death (182). Due 
to a series of limitations (e.g., the need for a large sample size to demonstrate 
survival benefit), other more targeted cachexia-related outcomes would be 
preferable. In this sense, the majority of available studies focused on cachexia 
mechanisms and symptoms, including anthropometric and body composition 
measurements, evaluating nutritional status and physical function, as well as the 
impact of the intervention on patient's QoL and specific biomarkers (e.g., C-reactive 
protein, cytokines) (181-183). However, variability in terms of endpoints might 
lead to discordance in studies findings and reduce the comparability among trials, 
because, although an improvement in cachexia mechanisms and symptoms may be 
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the optimal goal, these parameters are not always related with each other and with 
patient’s survival (184). 
 
Treatment options in cancer cachexia 
Recently, the American Society of Clinical Oncology has released updated cancer 
cachexia management guidelines, highlighting that to date no validated therapies 
have been identified (185). In this context, literature proposes supportive care as a 
suitable approach to manage cancer-related cachexia. In particular, physical 
exercise, nutritional counseling, and supplementation, as well as psycho-
educational and psychological interventions, appropriately integrated with 
pharmacological agents, may curb weight loss, counteracting some mechanisms 
and symptoms associated with cachexia. Below, we present available options in 
each single modality. 
 
Pharmacologic treatments 
Pharmacologic options to face cancer-related cachexia are based on three primary 
mechanisms of action: i) stimulation of appetite, ii) reduction of inflammation and 
iii) enhancement of the anabolic potential. Among the appetite stimulants, 
randomized controlled trials investigating cannabis sativa (186) and nabilone (187) 
in patients with advanced cancer and a weight loss >5% in the previous six months 
did not found improvement in body weight, appetite, and QoL. Similarly, 
melatonin, tested in cachectic patients with lung or gastrointestinal cancer, was not 
efficacious in gain weight or in favorably modulating appetite, QoL, fatigue, levels 
of C-reactive or enhancing overall survival (188). On the contrary, anamorelin, a 
selective ghrelin receptor agonist, was associated with a significant improvement 
in weight and lean body mass, but no effect was found for strength and survival in 
the large randomized, double-blind placebo-controlled trials ROMANA 1 and 
ROMANA 2 (184). Additionally, another study in cachectic lung cancer patients 
with anamorelin has confirmed its effect on lean body mass and weight, reporting 
an improvement in appetite and QoL (189). Several cytokine modulators have been 
evaluated for their potential impact to counteract cancer cachexia. Etanercept (190) 
and infliximab (191) reported inconsistent results on appetite (190, 191), 
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bodyweight (190, 191), QoL (190) and survival (191). However, both studies 
included patients not selected for weight loss history (190, 191). Also, 
pentoxifylline failed to increase weight and QoL in a randomized controlled trial 
including 70 advanced cancer patients with cachexia (192). While thalidomide 
increased body weight and arm muscle mass, no effects were detected on strength, 
QoL, and survival (193). Regarding anabolic agents, insulin was evaluated in 138 
cachectic patients with advanced gastrointestinal cancer (194). Insulin was found 
to stimulate carbohydrate intake, to increase body fat and survival, but no positive 
results were shown for exercise capacity, physical activity level, QoL, appetite, lean 
body mass, and body weight (194). Enobosarm, given its tissue-selective anabolic 
and androgenic activity, was also tested in cachexia, showing an increase in lean 
body mass, exercise capacity, and patients' QoL (195). Nevertheless, the dropout of 
patients on adherence to treatment is still very high, especially in patients assisted 
in palliative care. With an appropriate sample size, further studies are needed to 
clarify the real contribution of pharmacologic agents in cancer cachexia. 
 
Physical exercise treatment 
In cancer patients, observational studies suggest that physical activity may increase 
survival (5), with preclinical data confirming the role of exercise in tumorigenesis 
inhibition (196). Moreover, in the oncological setting, exercise is a recognized tool 
to alleviate treatment-related side effects (e.g., fatigue, sleep quality, cardiotoxicity, 
anxiety, and depression) (7, 10). The American College of Sports Medicine has 
released the last update for exercise in cancer patients, recommending that the 
patients should engage in at least 90 minutes per week in aerobic activity at 
moderate intensity and two days per week in resistance training (7).  
However, most of the available studies on exercise in cancer have been performed 
in patients affected by an early-stage disease. Focusing on patients with advanced 
disease, in which cachexia may occur more frequently, at first sight, exercise might 
seem contraindicated due to its requirement for energetic expenditure; instead, it 
might represent an advantageous strategy to counteract some mechanisms related 
to cachexia syndrome. Physical exercise in advanced cancer was safe, feasible, and 
well tolerated by patients (197). Moreover, a recent systematic review, including 
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25 studies for a total of 1,188 patients with mixed advanced cancers, found that 
exercise was able to increase aerobic and functional capacity, improve fatigue, 
QoL, and psychosocial function, as well as increase lean body mass without 
affecting the fat one (198). In particular, resistance training promotes muscle 
anabolism and inhibits protein catabolism, resulting in myofibrillar hypertrophy 
and enhancement of muscle strength through different mechanisms, such as mTOR 
pathway activation and increased levels of IGF-1 (199-201). Moreover, preliminary 
studies found that exercise positively modulates chronic low-grade inflammation, 
decreasing pro-inflammatory cytokines, like TNF-α and IL-6, and increasing those 
with an anti-inflammatory function (e.g., IL-1a and IL-10) (199, 200, 202, 203). 
Although a strong rationale supports exercise as a crucial therapeutic option for 
managing cachexia and its symptoms, future trials should investigate this strategy 
and determine the best appropriate program. 
 
Nutritional intervention 
The nutritional intervention has been advocated as the cornerstone of a multimodal 
intervention against cancer cachexia (152). A reduction in the supply of energy and 
protein and/or an increased demand lead to the exhaustion of substrates from the 
existing body stores (204). It is not plausible to increase or stabilize weight if 
nutritional needs are not met (205). Most patients with advanced cancer and weight 
loss have eating habits that are likely to be insufficient to maintain weight, even in 
healthy individuals. In this light, recent data from a retrospective study have shown 
that more than 80% of patients referring to the clinic for cancer cachexia were not 
consuming recommended levels of protein and energy (205). As previously 
mentioned, several symptoms may hamper the normal food intake in cancer 
patients, which should be recognized early and specifically treated (206). 
Optimization of patient’s protein and energy intake through an appropriate dietary 
counseling is the first step, as weight-stable cachectic patients have been shown to 
have higher intakes of protein and energy than those who were continuing losing 
weight (207). Dietary recommendations should consider the usual diet, personal 
eating patterns, manageable food consistency, and medical conditions. If 
spontaneous food intake remains insufficient after dietary consultation and oral 
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nutritional supplements have been deployed, escalation to artificial nutritional 
support is an option (208). Regarding oral supplementation different compounds, 
as β-hydroxy-β-methylbutyrate and L-carnitine, have been studied, but to date 
insufficient data exist to largely recommend them (209, 210). Omega-3-fatty acids 
seem promising in increasing appetite and body weight thus the guidelines on 
nutrition in cancer support their use (208). Even if several studies found 
heterogeneous results about nutritional intervention in cachexia, emerging data 
showed that closing the nutritional gap early during anticancer treatment could 
prevent further weight and muscle loss, with a possible effect on survival outcomes 
(211). 
 
Psycho-educational and psychological intervention 
Although literature limitedly considers the psychological support in cancer 
cachexia, cachectic patients are recognized to experience a range of psychological 
symptoms (212). Moreover, the burden of cachexia also impacts on family 
members and on patient/family relationships, as recently reported in a survey, 
which found high levels of eating-related distress in 702 bereaved family members 
(213). Thus, providing patients and their families with information, delivered by a 
psycho-oncologist or alternatively by a specifically trained nurse, about their 
condition and educating them on effective self-management skills may be a good 
strategy for cancer patients (169). In this sense, psycho-educational and 
psychological intervention should favor action-oriented, brief interventions, 
delivering a condensed package of "core" cognitive-behavioral skills (154, 214, 
215). Such strategies may include, but are not limited to, cognitive restructuring or 
cognitive reframing techniques, identification of dysfunctional thinking patterns, 
stress and relaxation management skills, behavioral activation, social skills 
improvement, and expressive supportive therapy (216). The shift to the conscious 
control of eating is often useful, through a reframe of eating as a necessity, rather 
than a pleasure, for promoting health outcomes such as slowing the disease 
progression, tolerating the side effects of chemotherapy, and maintaining strength 
and resistance (217). Teaching cognitive reframing strategies also permits patients 
to take control of eating habits, supporting self-efficacy,  empowering themselves 
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and improving their QoL(217). Despite some trials have investigated the impact of 
psychotherapy in advanced cancer patients (218, 219), currently ongoing studies 
may confirm the positive effect also in cachectic patients (220). 
 
A multimodal strategy for a multifactorial syndrome 
Cancer-cachexia may hardly be managed and reversed using a single intervention, 
given its multifactorial nature. It is reasonable to hypothesize that a multimodal 
management may offer the best treatment strategy (221, 222). Indeed, integrated 
exercise-based, and nutritional interventions combined with an appropriate 
pharmacological therapy could produce a synergistic effect, leading to effectively 
control or even counteract cachexia (221). For instance, the increase in muscle mass 
may be synergistically influenced by the four interventions. Exercise can provide 
an important anabolic stimulus to increase size and number of fast-twitching fibers 
that may also be improved by specific drugs. However, protein turnover requires 
adequate protein intake. In that respect, nutritional counseling can offer an optimal 
strategy to increase the quality of food assumption, while appetite-stimulating drugs 
could favor hunger and, consequently, lead to a higher caloric assumption (223).  
Although a strong rationale reinforces the use of a multidisciplinary approach, 
limited and preliminary studies have evaluated the combination of different 
interventions in managing cancer cachexia. A retrospective study has evaluated a 
multimodal approach in 374 cancer patients, exhibiting weight loss in the previous 
six months equal to 10% and an impaired QoL (224). The intervention, lasting about 
12 weeks and including medications to control symptoms (when appropriate), 
nutritional and exercise treatments, resulted in a clinically significant improvement 
in QoL that was greater in those patients who gained weight and increased their 
functional capacity (224). The NEXACT feasibility trial tested an eight-week 
multimodal intervention of tailored exercise plus nutrition in advanced lung and 
pancreatic cancer patients at high risk of cachexia. The exercise intervention 
consisted of resistance activities and steps program while nutritional support 
involved a tailored counseling and oral supplementation of branched-chain amino 
acids, coenzyme Q10, and L-carnitine. Although no relevant improvements in 
outcomes, such as lean body mass, weight, strength, and functional capacity, were 
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observed, the approach was safe and feasible, with good patients’ compliance (225). 
The only available randomized phase II trial, called MENAC, investigated a six-
week integrated approach in patients with incurable lung or pancreatic cancer 
undergoing chemotherapy (226). The intervention involved exercise, twice a week 
of aerobic plus resistance training three times per week, nutrition, counseling plus 
omega-3-fatty acids supplementation, and pharmacological agent (celecoxib). The 
MENAC program was considered safe and feasible, though the compliance for oral 
supplementation resulted suboptimal, stabilizing body weight in the interventional 
arm, while the controls lost weight (226). However, NEXACT and MENAC were 
not powered to show program efficacy. Currently, large trials are ongoing and may 
enhance the understanding of multimodal strategy effect on clinically relevant 
outcomes in cancer cachexia (NCT04065815; NCT04131426; NCT02330926).  
 
Expert opinion 
Cancer cachexia has been considered a terminal cancer-related event, substantially 
refractory to available treatments and amenable to only palliative support. 
Mounting evidence consistently suggests that cachexia can be considered an early 
phenomenon which should be managed as soon as possible during the disease 
course. Moreover, interventions should start early in order to avoid the worsening 
of cachexia and prevent the cachexia-related symptoms exacerbation. Thus, it is 
imperative to regularly assess patients in order to identify those cachectic or 
potentially at risk earlier before treatments refractoriness occurs. 
Although a series of studies improved knowledge about cancer cachexia, several 
issues are still open. Firstly, refine the diagnostic criteria for cancer cachexia may 
have an enormous influence to identify/categorize cachectic patients in order to 
direct them to a prompt intervention and select a homogeneous study population for 
trials. Secondly, it is necessary to recognize optimal endpoints and appropriate 
assessment tools to appropriately compare the interventions and establish their real 
impact counteracting this devastating syndrome. In addition, cancer cachexia 
remains still an orphan condition in terms of effective therapeutic strategies. 
Evidence suggests that a multimodal therapy, including pharmacologic agents, 
exercise and nutrition, would likely represent the best strategy to manage cachexia 
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and its related symptoms and ideally to improve not only the quantity but also the 
quality of patient's life. From our point of view, the introduction of a psychological 
intervention, conducted by a psycho-oncologist or alternatively by a specifically 
trained nurse, in the context of the multimodal approach could crucially contribute 
to cachexia management (Figure 1), favoring the adherence to the other treatments 




Figure 1. Multidisciplinary approach to manage cancer-related cachexia. 
 
Following this direction, in our Department of Oncology at the University of 
Verona, an interdisciplinary group, called the FORCE team (Focus On Research 
and CarE) was specifically created for cancer patients. Such team is led by a 
medical oncologist and includes a dietitian with documented skills in evidence-
based dietetic practice in cancer patients, a psycho-oncologist, and a kinesiologist, 
116 
 
who work as an integrated team to optimize and personalize each intervention, 
according to patient's characteristics, needs, and preferences. The multimodal 
intervention, with appropriate assessments, starts early in the disease journey and 
continues during treatment in order to support weight and muscle maintenance and, 
ideally, prevent the progression towards more advanced stages of cachexia. The 
team tries to deliver comprehensive care and access to the best therapeutic options, 
according to currently available guidelines, as well as to produce solid scientific 
evidence in order to increase knowledge in this still relatively unexplored field of 
research (229).  
Overall, the multimodal approach requires greater efforts in terms of staff 
specialists, facilities, and economic availability. Nevertheless, if this will prove to 
represent a winning strategy against cancer cachexia and improve patients’ QoL, its 
implementation in clinical practice as a standard of care will be indispensable and 
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Introduction: Pancreatic cancer remains an aggressive disease, with a poor 
prognosis and a high risk of incurring into cachexia. Supportive care, such as 
exercise, nutritional and psychological support, may be effective in reducing 
functional loss, psychological distress, and improving nutritional status. Case 
presentation: We report the effect of 12 weeks of multimodal lifestyle intervention 
in a 55-year-old female, diagnosed with unresectable body/tail pancreatic cancer 
and metastasis in the liver, bone, lymph node, and lung, to counteract cachexia. 
Results: The multimodal program resulted safe and feasible. Over 12 weeks, 
considerable improvements were found in body weight, health-related physical 
fitness, nutritional status, distress scores, anxiety, and depression levels. 
Conclusions: These findings highlight the potential role of integrated supportive 





Although relatively uncommon (2.5% of all cancers), pancreatic cancer (PC) 
remains a lethal malignancy, with a ratio mortality/incidence of 94% and a 5-year 
survival rate of only 9% (230). To date, effective therapies are available to improve 
prognosis and relieve patient's symptoms. Surgery with curative intent represents 
the main opportunity for "cure", even though the vast majority (~85%) of patients 
presents with unresectable disease (231). Chemotherapy (mostly gemcitabine- and 
fluorouracil-based polychemotherapy combinations) has a definite impact on 
survival in both resectable and advanced disease, and radiation therapy is used 
mainly to treat locally advanced, inoperable disease (231).  
PC patients are at high-risk of cachexia, a multifactorial syndrome characterized by 
an ongoing loss of skeletal muscle mass that cannot be fully reversed by 
conventional nutritional support and leads to progressive functional impairment 
(152). Currently, no standard treatments are available to contrast the progression of 
cancer cachexia (232). In light of its dismal prognosis, advanced PC treatment 
remains palliative in nature, and managing patients' physical function and 
preserving their quality of life (QoL) is at least as important as extending survival 
(233). Supportive multimodal care, physical exercise, dietary guidance, and 
psychological support, have established efficacy to counteract many cancer- and 
treatment-related side effects (7, 208) and might represent a useful approach to treat 
or prevent cancer-induced cachexia. Exercise is a potent body modulator, able to 
increase cardiorespiratory fitness, strength, and muscle mass, which, in turn, 
represent independent predictors of survival in cancer; moreover, increased 
physical fitness may counteract some disabling cancer symptoms, such as fatigue, 
nausea, pain, anxiety, and depression (7). Food intake optimization has been 
recognized as a crucial approach in the treatment of PC patients, considering that 
they frequently suffer from malnutrition and experience a reduced food intake due 
to several reasons (e.g. loss of appetite, anorexia, maldigestion and malabsorption, 
vomiting, nausea) (234). Therefore, increasing energy intake and protein balance 
with a personalized nutritional counseling can improve body composition, prevent 
weight loss, and manage some cancer- and treatment-related side effects (152). 
Finally, PC patients usually report a high level of distress, which can exacerbate 
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symptoms burden, impair QoL, and interfere with medical treatments (235). 
Psychotherapy, including cognitive-behavioral therapy, problem-solving therapy, 
or mindfulness-based approaches, for example, has demonstrated to reduce anxiety 
and depression levels in advanced cancer patients (227). Moreover, psychological 
support can be effective to manage cancer-related fatigue, reduce fear, and improve 
global well-being (227). 
Exercise, nutritional and psychological support complement each other, possibly 
resulting in synergistic potentiation of the expected clinical benefit by the 
appropriate combination of these interventions, particularly in a complex and 
aggressive disease such as PC. Nevertheless, safety and feasibility of an integrated, 
multimodal approach in advanced cancer with cachexia is still a relatively 
unexplored area. Here, we report the results of a three-month supervised, integrated 
supportive intervention, carried out by a dedicated multidisciplinary team (Focus 
On Research and CarE - FORCE - team), including exercise, nutritional counseling, 
and psychological support in an advanced, metastatic PC patient with cachexia 
undergoing II/III-line chemotherapy. 
 
Case presentation 
A 55-year-old woman presented in January 2019 with unintentional weight loss and 
abdominal pain. Computer tomography of the abdomen and subsequent ultrasound-
guided fine-needle aspiration biopsy led to the diagnosis of an unresectable 
body/tail pancreatic cancer (stage III according to TNM classification). She 
underwent chemotherapy with a combination of fluorouracil, leucovorin, 
irinotecan, and oxaliplatin (FOLFIRINOX), but after three months disease 
progressed with appearance of liver and bone metastases (Figure 1). Second-line 
chemotherapy was then started with gemcitabine/nab-paclitaxel in June 2019, 
resulting in disease stabilization and temporary clinical benefit. In November 2019 
disease progressed further, involving abdominal lymph nodes, liver, lung and 
bones, and resulting in a malignant upper left urinary tract obstruction, which 
required invasive palliation by nephrostomy.  
At the time of observation by the FORCE team (November 2019), with a weight 
loss of 21.4% over the past 6 months without starvation the patient was considered 
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cachectic (according to EPCRC criteria (170) and the ECOG performance status 
was 1. Despite the current lack of survival benefit in this setting, therapeutic 
options, including best supportive care, were discussed with the patient and she was 




Figure 1. Timeline of disease status and multidisciplinary lifestyle intervention 
 
At the same time, she was offered to participate into an integrated three-month 
multimodal program, including exercise, nutrition, and psychological intervention. 
The three-month period was considered an adequate time frame to achieve a 
meaningful change in weight, also considering the prognostic expectation at this 
disease stage (236).   
The study was conducted according to the Declaration of Helsinki, the Good 
Clinical Practice and was reported following case report (CARE) guidelines (237). 
The authors obtained patient’s consent for publication of clinical data. The patient’s 
personal details were anonymized.  
 
Multimodal intervention 
Exercise. An individual exercise program based on the American College of Sports 
Medicine guidelines (7) and supervised by an experienced kinesiologist, was 
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conducted with the aim to improve cardiorespiratory fitness and increase muscle 
mass and strength. Baseline evaluation included cardiorespiratory fitness, strength, 
flexibility (Table1), and complete medical history. A twice-weekly program was 
implemented, with each session lasting 60 min and including in order: warm-up, 
aerobic exercises, strength activities, and cool-down. Fifteen-min warm-up and 
cool-down phases comprised dynamic and static flexibility exercises, respectively. 
The load of aerobic activity, consisting in cycling and walking ergometer, was 
slowly increased from 10 min at the beginning to 25 min at the end of the program, 
with an intensity level of 3 to 5 on the CR10 Borg Scale of perceived exertion. 
Resistance training included six exercises with bodyweight and resistance bands 
(Thera-Band, Hygenic Corp. Akron OH), covering major functional lower- and 
upper-body muscle groups. Each strength exercise was performed at 3 to 5 on the 
CR10 Borg Scale of perceived exertion, in two-three sets of 8-12 repetitions, which 
were progressively increased during the training program. 
Nutritional intervention. Nutritional intervention had the main objective to meet 
patient's energy and protein requirements and to effectively manage disease- and 
treatment-related symptoms with a nutritional impact. Nutritional counselling was 
carried out bi-weekly, in presence, by a registered dietitian with experience in 
cancer care: intervention consisted in a personalized dietary prescription, including 
sample meal plans and suggested recipes, tailored to patient's own eating patterns 
and preferences. Patient was invited to take more time to eat, increase the daily 
number of meals and snacks, and favor high-protein and -energy food. Total daily 
energy requirements were calculated at baseline by the Harris-Benedict equation, 
corrected by a factor of 1.5 (208), whereas daily protein requirement was set at 1.5 
g/kg of actual body weight (208). Since spontaneous oral intake was insufficient to 
cover needs, oral nutritional supplements, with high protein and calories content, 
were proposed (208). Finally, pancreatic enzyme replacement therapy (PERT) was 
prescribed for the management of malabsorption symptoms: The initial PERT dose 
was 40,000 U Ph Eur and 25,000 U Ph Eur of lipase per meal and per snack, 
respectively. The patient was trained to take PERT during the meal and to adapt the 
dose based on meal size and fat content; clinical symptoms and the presence of 
steatorrhea were evaluated bi-weekly. 
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Psychological support. Weekly psychological support sessions were carried out, 
with each meeting lasting about 60 minutes. Using cognitive behavioral therapy, 
the primary focus of psychological treatment was helping the patient to reduce 
anxiety, depression, and distress levels. After baseline assessment, based on current 
guidelines (238), intervention started from behavioral reactivation, with the aim to 
implement patient's daily living activities. Through cognitive restructuring, the 
existing dysfunctional and irrational thoughts were modified, promoting useful and 
functional ones. Moreover, a mindfulness-based approach was proposed to 
implement patient's quality of sleep, reducing the nightly awakening and the 
ruminations. The sessions also incorporated progressive relaxation techniques and 
controlled breathing, to decrease muscle tension. 
 
Assessments 
Outcome measures were assessed at baseline and at 12 weeks. At baseline, 
demographic information was self-reported, whereas clinical data were derived 
from the electronic patient data management system. Resting heart rate and blood 
pressure were evaluated before health-related fitness assessment, after 10 min of 
rest in the supine position. 
Safety and feasibility. Safety was classified as intervention-related adverse events, 
occurring as a direct result of exercise or nutritional or psychological support and 
categorized according to the Common Terminology Criteria for Adverse Events 
(version 5.0). Feasibility was re-evaluated continuously during intervention, 
recording the adherence to each intervention, i.e. the number of sessions attended 
by the subject, compared to the total planned.  
Health-related physical fitness. A series of tests were performed to evaluate the 
physical and functional capacity of the patient. Six minutes walking test was used 
to assess cardiorespiratory fitness, according to the American Thoracic Society 
guidelines (116). The test consisted in walking in a 20-m hallway, with the goal to 
cover as much distance as possible in six minutes. Standardized encouragements 
were given and the time remaining was called out every minute. Muscular strength 
was evaluated with the handgrip strength test, using a hydraulic hand dynamometer 
(Model SH5001, Saehan Corporation, Korea). The subject was sitting in a straight-
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backed chair with the feet flat on the floor, the shoulders in adducted and neutral 
position, and the wrist between 0-30 degrees extension and between 0-15 degrees 
ulnar deviation. For both arms, five tests were performed, and each voluntary 
contraction was kept for 2-4 seconds, with one-minute rest between the tests. The 
highest achieved value in each hand was reported (118). Flexibility was evaluated 
for upper- and lower-limbs, using back scratch and chair sit and reach test, 
following the protocol proposed by Rickli and Jones (239). Anthropometric 
parameters included body mass index (BMI), obtained by the weight of the subjects 
divided by the square of her height and waist-hip ratio, derived by the ratio of waist 
and hip circumferences, according to standard procedures (240).  
Nutritional assessments. Nutritional risk screening (NRS-2002) was adopted to 
evaluate nutritional risk through the following variables, referred to the previous 
week: weight loss, BMI, general conditions, amount of food intake, age, and 
severity of the disease. According to the scoring protocol the patient is classified at 
nutritional risk (score equal or more than three) or not (score less than three) (241). 
The dietitian collected the presence of symptoms potentially affecting patient's 
feeding, such as early satiety, loss of appetite, dysgeusia, dyspepsia, chemotherapy-
induced nausea and vomiting, xerostomia, and symptoms of malabsorption, 
including increased abdominal bloating or discomfort, excessive gas causing 
burping or flatulence, increased frequency, light color, floating, frothy, oily, and/or 
foul-smelling faeces. Energy intake was assessed by a 3-day 24-h dietary recall 
method (2 weekdays and one weekend day). The nutrient contents of foodstuffs and 
meals were analyzed by the Food Composition Table of National Institute for 
Research on Food and Nutrition. This energy intake was comparable to the patient's 
optimal nutritional requirements. Inadequacy of energy intake was considered in 
the event of a current energy intake <60% of estimated requirements for more than 
1–2 weeks, according to the most recent guidelines for nutrition in cancer patients 
of the European Society for Clinical Nutrition and Metabolism (ESPEN) (208). 
Body composition was assessed using the NUTRILAB BIVA (Akern s.r.l., 
Florence, Italy), according to previously described procedures (242). 
Psychological and patients reported outcomes. A series of questionnaires were 
proposed to evaluate psychological status, QoL, and physical activity level. 
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Psychological status was assessed using validated tools: Hospital Anxiety and 
Depression Scale (HADS) and the Distress Thermometer (DT) (243). HADS, is a 
self-reported questionnaire composed by 7-item regarding anxiety (HADS-A) and 
7-item concerning depression (HADS-D) and reflects how the patient felt in the 
previous week. Both scales ranging from 0 to 21, and a score of 8-10 reflect 
borderline symptoms while scoring ≥ 10 indicates the presence of clinically relevant 
of anxiety and depression (243). DT is a single-item question, in which on an 11-
point numerical analogue scale the subject quantified her distress from 0 (no 
distress) to 10 (extreme distress). A score equivalent to or greater than 4 suggests a 
clinically significant level of distress (244).  The European Organization for 
Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ C-
30) was used to assess the quality of life. The EORTC QLQ C-30 is a 30 items scale 
that measures global health status (2 items), symptoms subscale (13 items: fatigue, 
pain, nausea, vomiting, dyspnea, sleep disturbance, constipation, diarrhea, appetite 
loss, and difficulties score), and functional scale with social functioning, physical 
functioning, cognitive functioning, and emotional functioning scores (15 items) 
(122). Physical activity level was assessed through the modified Godin Leisure-
Time Exercise Questionnaire, in which the weekly duration, as well as the 
frequency of light, moderate and vigorous activity, were reported (58). 
 
Results 
No adverse events related to the integrated, multimodal approach were recorded 
during the 12 weeks of intervention. Compliance to the multimodal program was 
high: 83% (20/24) for exercise, 100% (6/6) for nutritional counseling, and 75% 
(9/12) for psychological support sessions, respectively. Reasons for missing 
sessions were treatment-related side effects (fever) and invasive procedures 
(nephrostomy positioning). Exercise sessions were well tolerated, the nephrostomy 
bag did not interfere with the activity, and the planned progression was completed 
without modifications.  




Table 1. Absolute scores of health-related physical fitness and nutritional 
parameters 
 
Measure At baseline Post-intervention 
Resting blood pressure and heart rate   
Resting systolic blood pressure (mmHg) 103 109 
Resting diastolic blood pressure (mmHg) 70 61 
Resting heart rate (bpm) 68 61 
Six minutes walking test (m) 416.0 525.6 
Final heart rate 87 86 
RPE 3.0 3.0 
Handgrip strength (kg)   
Right arm 22 24 
Left arm 22 23 
RPE 4.0 5.5 
Chair sit and reach (cm)   
Right leg 0.0 0.0 
Left leg - 2.0 + 2.0 
Back scratch (cm)   
Right arm (upper) + 3.5 + 5.5 
Left arm (upper) + 4.0 + 3.0 
Anthropometric parameters   
Usual weight (kg)  63.0  
Usual BMI (kg/m2) 23.1  
6-months weight loss (%) 21.4  
Body weight (kg) 49.0 53.2 
BMI (kg/m2) 18.0 19.5 
Waist (cm) 67.1 70.5 
Hip (cm) 89.3 92.0 
Waist-hip ratio 0.8 0.8 
Body composition   
Phase angle (degrees) 2.9 3.8 
Body cell mass (kg) 7.5 10.4 
Total body water (l) 20.8 21.0 
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Fat mass (kg) 6.1 5.2 
Fat free mass (kg) 23.9 26.1 
NRS-2002 score 3.0 2.0 
Dietary assessments   
Estimated energy requirements (kcal/day) 1836  
Estimated protein requirements (g/kg/day) 1.5  
Baseline energy intake (kcal/day) 1271 1874 
Baseline protein intake (g/kg/day) 0.8 1.4 
Nutritional impact symptoms   
Early satiety Yes No 
Dysphagia Yes No 
Loss of appetite Yes No 
Dysgeusia No No 
Oral mucositis Yes No 
Dyspepsia Yes No 
Xerostomia Yes No 
Nausea/vomiting Yes Yes 
Diarrhea Yes No 
Steatorrhea Yes No 
Abdominal bloating Yes No 
 
Considerable improvements were observed for cardiorespiratory fitness (+ 26.3%), 
right handgrip strength (+ 9.1%), left handgrip strength (+ 4.5%), some parameters 
of upper and lower body flexibility and physical activity level (Table 1). Resting 
heart rate and blood pressure remained stable. Despite considerable weight loss in 
the six months (~21.4%) preceding intervention, anthropometric measures showed 
an increase in body weight, waist/hip values, and BMI from 18.0 kg/m2 to 19.5 
kg/m2. Body composition analysis revealed a considerable increment in fat-free 
mass (+9.2%) and an improvement in phase angle, from 2.9° to 3.8°. Nutritional 
status improved from a NRS-2002 score of 3 (at risk for malnutrition) at baseline 
to a NRS-2002 score of 2 (not at risk) at the end of the intervention. Moreover, a 
substantial increase in energy (+ 47%) and protein (+ 75%) intake above baseline 
was observed; several nutritional impact symptoms present at baseline, such as 
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dysphagia, oral mucositis, dyspepsia, xerostomia, diarrhea, steatorrhea and 
abdominal bloating, disappeared after 12 weeks (Table 1). QoL improved in certain 
domains, such as physical functioning, emotional functioning, social functioning, 
appetite loss; on the contrary, some symptoms especially fatigue, nausea/vomiting, 
pain, dyspnea, and insomnia worsened during the intervention period; overall health 
status remained unchanged (Table 2).  
 
Table 2. Absolute scores of patient-reported outcomes 
Measure At baseline Post-intervention 
Quality of life (score 0-100)   
Physical functioning 73.3 80.0 
Role functioning 50.0 50.0 
Emotional functioning 75.0 83.3 
Cognitive functioning 83.3 83.3 
Social functioning 33.3 66.7 
Global health status 50.0 50.0 
Fatigue 55.6 66.7 
Nausea/vomiting  16.6 33.3 
Pain  33.3 50.0 
Dyspnea  33.3 66.7 
Insomnia  33.3 66.7 
Appetite loss 33.3 0.0 
Constipation  0.0 0.0 
Diarrhea 66.7 66.7 
Financial problems 33.3 33.3 
Physical activity level (min/week)   
Vigorous 0.0 0.0 
Moderate 0.0 0.0 
Light  210.0 420.0 
Psychological status (score 0-21)   





Hospital Anxiety and Depression Scale – 
depression 
18 11 
Distress Thermometer 8 4 
 
 
A clinically relevant status of depression and distress remained stable at both 
baseline and post-intervention time points, while anxiety improved at 12 weeks, 
resulting in a borderline abnormal level. However, a considerable reduction in 
HADS-A (from 16 to 9 points), HADS-D (from 18 to 11 points), and DT (from 8 
to 4 points) were observed (Table 2).  
 
Discussion 
This case study highlights the fact that a multimodal intervention including 
exercise, nutritional, and psychological support carried out by a dedicated 
multidisciplinary team (FORCE team) is feasible and safe during palliative 
chemotherapy for a cachectic patient affected by advanced PC. Indeed, no adverse 
events related to the intervention occurred and the compliance to the three 
interventions was excellent. Demonstrating the safety of an exercise program, even 
in the context of an aggressive oncological disease such as PC and in a patient, who 
recently underwent an invasive palliative procedure, may help to overcome barriers 
towards physical exercise in this setting (245).  
Weight loss is one of the most important factors involved in cancer cachexia (234). 
Approximately 80% of PC patients present cachexia, which is also a predictor of 
poor outcomes throughout all disease stages. As evidenced by this case study, 
structured multidisciplinary assessment, counselling, and intervention, resulted in a 
substantial (~4.2 kg) increase in body weight (234). It is worth noting that weight 
gain is an essential component of the so-called clinical benefit response (CBR), a 
composite endpoint specifically developed to evaluate treatment impact in PC (246, 
247) and validated as a surrogate endpoint for survival in this setting (248). 
Moreover, exercise capacity, muscular strength and mass are prognostic factors in 
PC (211, 249) and are often impaired due to both cachexia and cancer diagnosis 
(250, 251). On one side, resistance training is a potent modulator of skeletal 
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muscles, able to increase strength and muscle mass, whereas aerobic training can 
control inflammatory and immune response (199). On the other hand, adequate 
caloric, and especially protein, intake is a key component helping to increase or 
preserve muscle mass (234). An integrated, synergistic approach can favor protein 
turnover and increase their skeletal muscle synthesis. Our multimodal intervention 
resulted in an improvement in cardiorespiratory fitness, muscular strength, and 
mass; it helped correcting nutritional deficiencies, increasing nutritional intake to 
meet or exceed optimal requirements, and managing nutritional impact symptoms.  
Overall, it could be speculated that an increase in functional capacity, adding an 
adequate caloric, especially protein, intake, and a gain in body weight, can improve 
muscle mass and consequently prevent or control cachexia (Figure 2). 
 
 
Figure 2. Multidisciplinary intervention as strategy to manage cancer cachexia 
 
 In addition, psychological intervention may also indirectly contribute to managing 
cancer cachexia. We found that distress and depression reduced substantially, and 
anxiety moved from abnormal levels to borderline. Consistently with a previous 
study (236), quality of life reported improvement in some domains, while others 
showed no change or worsening, probably due to disease progression and change 
in the treatment regimen in the last two weeks of intervention. Patients with 
advanced cancer or with cachexia may suffer from psychological distress, and 
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several prior investigations have identified eating-related distress as a significant 
contributor to these symptoms (252). Moreover, psychological intervention can 
help patients to feel better, but it can also support the multimodal intervention 
through better uptake and adherence (Figure 2).  
To our knowledge, only one trial tested the feasibility of the multimodal approach, 
including exercise, nutritional supplements, and anti-inflammatory drugs, for the 
management of cachexia in lung and pancreatic cancer (MENAC trial) (226). This 
study has the strength to be a randomized controlled trial, and the results showed 
an improvement in muscle mass and body weight, while no changes were observed 
for strength and exercise capacity. However, compared to our case-study, the 
MENAC trial, reported lower levels of intervention adherence, and the program 
lasted only six weeks (226). Adherence is an important modifiable factor, affecting 
treatment outcome, and probably represents the most relevant aspect to expect 
beneficial results from an intervention (253, 254). These may suggest that longer 
intervention and/or higher adherence are needed to improve the expected results.  
The main limitation of this case report is the absence of specific blood tests, which 
could provide additional information about the patient's inflammatory and 
immunological status. Nevertheless, this case is unique for both the patient's 
condition and the multimodal intervention proposed.  
 
Conclusion & future perspectives 
We found that intervention, including exercise, nutritional and psychological 
support, is safe, feasible, and efficacious. Given the clinical importance of the 
observed results, prospective trials incorporating a multimodal lifestyle approach 
with a solid design are needed to validate the real benefit and definitely implement 






SUMMARY OF THE THESIS RESULTS 
 
The purpose of the present dissertation was to enhance the knowledge about 
exercise in Italian cancer patients. To this aim: 1) exercise preferences, barriers, and 
cues to action in cancer patients were investigated, 2) a tailored exercise program 
was developed, 3) the inclusion of exercise as part of multidisciplinary intervention 
was preliminarily tested. 
 
The study results can be summarized as follows: 
 
Study 1: This study shows that 93% of cancer patients are insufficiently active, 
with similar exercise behavior in men and women through age. Nevertheless, 
roughly 80% of the study participants are willing to start and exercise program, 
specifically designed or cancer patients. The willingness to start an exercise 
program is associated with some socio-demographics and medical variables, as age, 
education, and cancer treatment. Exercise preferences in cancer patients tend to 
vary substantially, suggesting that different exercise proposals may be offered to 
address patients’ needs. 
 
Study 2: This qualitative study reports that several factors can influence the 
adoption of an active lifestyle in cancer patients. Patients have a positive perception 
of physical activity, reporting a variety of related benefits. A series of barriers have 
been identified, especially related to disease, medical treatments, and risk of injury. 
By the contrary, several strategies, as an available exercise specialist and a targeted 
physical activity program, may motivate and facilitate patients to start or maintain 
a physical activity program. 
 
Study 3: Study 1 and 2 provided important information to develop one of the first 
exercise intervention on cancer patients in Italy. The CHOiCE study is a two-sites, 
prospective, two-armed, phase II randomized controlled trial, aiming to explore 
program’ safety and feasibility as well as preliminary efficacy on health-related 
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skills and quality of life. Patients randomized in the interventional arm can choose 
to perform exercise between three modalities: a written exercise program to perform 
at home, an individual supervised program, and a group-based program. The 12-
week of exercise, consist of aerobic, strength and activities, based on baseline 
evaluations and progressively increasing over the weeks. There is a dearth of 
knowledge about exercise oncology in Italy. CHOiCE study tries to bridge this gap 
seek to propose a program addressing patients’ needs. 
 
Study 4: COVID-19 pandemic storm is relentlessly progressing worldwide, 
disrupting, and slowing down of routine medical care and research and activity 
related to exercise. Physical inactivity, imposed by the pandemic emergency, may 
have negative and long-term effects in cancer patients. Adaptations of the current 
exercise guidelines, through remote approaches, e.g., home-based exercise 
programs, may help to counteract the sedentary and mitigate the risks deriving from 
it. 
 
Study 5: Cancer cachexia remains still a critical point in cancer care, without 
validated therapies. The multifactorial pathophysiology of this syndrome supports 
the use of multimodal interventions. Theoretically, pharmaceutical agents, exercise 
nutrition and psychological support may produce a synergistic effect, able to 
manage and/or improve cancer-related cachexia. However, to offer a personalized 
program a specialized staff is necessary, requiring efforts also in terms of economic 
availability. 
 
Study 6: In a case of metastatic pancreatic cancer with cachexia, a multimodal 
approach, including exercise, nutrition and psychological support was proposed. 
The intervention consisted in a personalized aerobic and strength activities 
performed twice a week, tailored nutritional intervention with bi-weekly counseling 
and psychological support once a week. A 12-week intervention was safe and 
feasible, showing positive effects to gain weight, enhance strength and functional 




Although, each study has its own limitations, discussed in the respective chapters, 
this dissertation may provide some important findings about exercise in Italian 
cancer population. Further studies should continue to study the effect of exercise 
and its combination with other interventions in the cancer care. On the other hand, 
in Italy, the dissemination of exercise programs to support cancer patients are 
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